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Abstract 
Microorganisms can be used in bioprocesses to produce various chemicals, such as 
fuels, cosmetics and medical products, as an environmentally friendly alternative for 
chemical synthesis. In these bioprocesses the raw materials (e.g. lignocellulose) can be 
converted to compounds with high complexity with a minimum energy input and waste 
material production. The metabolic capabilities and robustness of the bioprocess host 
organism limit the yield and purity of the product. Molecules that currently cannot be 
produced efficiently with robust microbial host organisms include wax esters, which have 
several industrial applications and are currently produced with the Jojoba plant. 
Acinetobacter baylyi ADP1 is a non-pathogenic soil bacterium that produces wax esters 
that can readily incorporate foreign DNA into their genome and utilize various plant-de-
rived molecules as a carbon source. For these reasons, A. baylyi ADP1 has become a 
model organism of bacterial genetics and metabolism, which has led to the accumulation 
of a vast amount of information about its biology. This Doctor of Science thesis describes 
experiments where the metabolism of A. baylyi ADP1 was engineered for improved 
growth and wax ester production using lignocellulose-derived molecules as raw material. 
With a gene knockout (rmlA) and expression of a foreign gene (pykF), it was possible to 
double the growth rate of A. baylyi APD1 on glucose, double the molar wax ester yield 
from glucose while improving product purity and collection of the cells. An additional gene 
knockout (poxB) improved growth and wax ester production in the presence of acetate, 
a common growth inhibitor found in lignocellulosic hydrolysates. A combination of these 
modifications led to a strain that produced 0.45 g/l of wax esters in a medium containing 
glucose, amino acids from casein hydrolysate and acetate as carbon sources. In addition, 
a biodetoxification strain for the removal of inhibitors produced in the pretreatment of 
lignocellulosic biomass was produced with a single gene knockout. 
While significant improvements in growth and wax ester production of A. baylyi ADP1 
from components of lignocellulosic hydrolysates were obtained with metabolic engineer-
ing, the wax ester production needs to be further improved if this strain is going to be 
used in industrial applications. The strains that were produced here can be used as plat-
form for further improvements of wax ester production by A. baylyi ADP1. 
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Tiivistelmä 
Mikro-organismeja voidaan käyttää erilaisten kemikaalien, esim. polttoaineiden, kosme-
tiikkatuotteiden ja lääkeaineiden, tuottamisessa bioprosesseissa, jotka tarjoavat ympä-
ristöystävällisemmän vaihtoehdon kemialliselle synteesille. Tällaisissa bioprosesseissa 
raaka-aineet (esim. lignoselluloosa) voidaan muuttaa monimutkaisiksi yhdisteiksi siten, 
että energiankulutus ja jätevirrat ovat minimaalisia. Bioprosesseissa tuotettujen yhdistei-
den saantoa ja puhtausastetta rajoittaa käytetyn tuotto-organismin aineenvaihdunta ja 
kasvuominaisuudet. Yhdisteisiin, joita hyvät kasvuominaisuudet omaavilla tuotto-orga-
nismilla ei voida tällä hetkellä tuottaa tehokkaasti, lukeutuu monia teollisia käyttökohteita 
omaavat vahaesterit, joita tällä hetkellä tuotetaan Jojoba-nimisellä kasvilla. 
Acinetobacter baylyi ADP1 on ihmiselle vaaraton maaperäbakteeri, joka tuottaa vahaes-
teitä, kykenee liittämään vierasperäistä DNA:a genomiinsa ja pystyy kasvamaan useilla 
kasviperäisillä hiilenlähteillä. Näistä syistä A. baylyi ADP1:stä on tullut yksi bakteerige-
netiikan ja –aineenvaihdunnan malliorganismeista, minkä vuoksi on kertynyt erittäin pal-
jon tietoa sen biologiasta. Tässä tekniikan tohtorin väitöskirjassa esitellään tulokset ko-
keista, joissa on muokattu A. baylyi ADP1:n aineenvaihduntaa tavoilla, jotka parantavat 
sen kasvuominaisuuksia ja vahaesterintuottoa, kun lignoselluloosaperäisiä yhdisteitä 
käytetään raaka-aineena. 
Yhdellä geenipoistolla (rmlA) ja yhtä vierasgeeniä (pykF) ilmentämällä pystyttiin kaksin-
kertaistamaan A. baylyi ADP1:n kasvunopeus ja vahaesterisaanto glukoosilla, paranta-
maan tuotteen puhtausastetta ja sen keräämisen helppoutta. Yhden geenipoiston (poxB) 
lisääminen paransi kasvua ja vahaesterintuottoa asetaatin, mikä on yleinen lignosellu-
loosahydrolysaattien kasvuinhibiittori, läsnäollessa. Nämä muokkaukset yhdistävällä 
kannalla pystyttiin tuottamaan 0,45 g/l vahaestereitä kasvuliemessä, mikä sisälsi glukoo-
sia, kaseiinihydrolysaatin aminohappoja ja asetaattia hiilenlähteinä. Tuotettiin myös eril-
linen kanta lignoselluloosahydrolysaatin inhibiittorien poistamista varten yhdellä geeni-
poistolla.  
Vaikka merkittäviä parannuksia pystyttiin tekemään A. baylyi ADP1:n kasvuominaisuuk-
siin ja vahaesterientuottoon lignoselluloosahydrolysaatin komponenteista, vahaesterin-
tuottoa pitää kuitenkin vielä parantaa, jotta tätä kantaa voitaisiin käyttää teollisissa so-
velluksissa. Kehitetyt kannat luovat pohjan sille, että A. baylyi ADP1:stä voidaan kehittää 
tällainen riittävän tehokas vahaesterientuotto-organismi. 
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The production of chemicals with microorganisms offers an environmentally friendly alternative 
to chemical synthesis. During the 20th century, bioprocesses were developed for the production 
of various chemicals, such as solvents like acetone and butanol, amino acids, vitamins, and 
antibiotics [31]. After the development of recombinant DNA technology, the range of products 
that can be produced in bioprocesses increased dramatically [31]. Not only did genetic engineer-
ing allow production of new products in well-studied organisms, like insulin production in Esche-
richia coli [10], it enabled improving existing host organisms and thus allowed greater yields of 
natural products to be achieved. Drugs produced with genetically engineered microorganisms 
can be produced more reliably than those extracted from natural sources [143]. For example, a 
precursor to the malaria drug, artemisinin, can be produced with genetically engineered yeast, 
which is expected to even out fluctuations in the availability of the drug [143]. Although high-
value products, such as drugs, can be produced in an economically feasible way using refined 
chemicals as a raw material, bulk chemicals need to be produced from less expensive raw ma-
terials. One such raw material is lignocellulosic biomass which includes wood and the inedible 
parts of food crops. The utilization of lignocellulosic biomass requires that its components are 
liberated in pretreatments, which also release compounds that can be inhibitory to the biopro-
cesses. 
Wax esters (WE) are lipids that can be used in many applications including cosmetics, biofuel 
production and in medical products [158]. WEs are currently produced from the Jojoba plant, 
which grows primarily in deserts [158]. If WEs could be produced efficiently with microorganisms, 
these lipids could be produced anywhere from inexpensive raw materials such as lignocellulose. 
Acinetobacter baylyi ADP1 (ADP1) is a soil bacterium that naturally accumulates WEs for energy 
and carbon storage [56]. It grows on various components of lignocellulosic hydrolysates and has 
a metabolism that is easy to engineer [204]. Currently, the WE yields obtained with ADP1 are 
not sufficiently high for economically feasible production of these storage lipids. In this thesis, it 
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was attempted to improve the growth and WE production of ADP1 using various components of 
lignocellulosic hydrolysates as a carbon source by means of metabolic engineering. 
In the Background section of this thesis, the composition and utilization of lignocellulosic biomass, 
the use of metabolic engineering to improve host organisms for bioprocesses and the biology of 
ADP1 are explained. Several excellent review articles have recently been published about ligno-
cellulosic hydrolysates [84], [85] metabolic engineering [93], [103], [131], [148], [203] and metab-
olism and genetics of ADP1 [29], [45], [204], and so they are covered here only briefly. The parts 
of the metabolism of ADP1 studied in the Publications I-IV are discussed more thoroughly. The 
metabolism of ADP1 has some peculiar aspects and it was attempted in the experiments to 
engineer those metabolic steps to improve growth and WE production. While many aspects of 
the metabolism of ADP1 have been studied extensively, there is no information available about 
certain parts of its metabolism. Those aspects of its metabolism which are relevant to this thesis 
are discussed with respect to the metabolism of E. coli, which is a fairly close relative of ADP1. 
Since E. coli is probably the most studied model bacterium, the differences between ADP1 and 
E. coli are also discussed. The hypotheses on which the experiments are based are described 
in the Research Objectives and Questions section. Materials and Methods briefly explains how 
the metabolic engineering and the experiments to test the engineered strains were performed. 
In the Results and Discussion section, the results of the experiments carried out for Publications 
I – IV are discussed and compared with the growth characteristics and WE yields of other micro-
organisms. In the Conclusions section, the overall success of the attempt to engineer the metab-
olism of ADP1 for improved growth and WE production is discussed. This section also includes 
an evaluation of whether the work carried out here has taken ADP1 closer to being a realistic 
choice as a host organism in bioprocesses where components of lignocellulosic hydrolysates are 
converted to WEs. Finally, suggestions for further improvements that need to be carried out in 
order to engineer ADP1 into an efficient WE producer are given. 
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2.1 Lignocellulosic hydrolysates 
Sugars and starch have been used in production of the first-generation biofuels, but since these 
raw materials could be also used as human food, and as a feedstock for animals, lignocellulosic 
biomass, which consists of the inedible parts of plants, has been considered as a better alterna-
tive [64]. Lignocellulosic biomass is also less expensive than starch, and can be cultivated with 
less use of fertilizers and on different land areas than food crops [64]. The composition of ligno-
cellulosic biomass varies greatly depending on the plant it is produced from [21]. In general, it 
can be said that it is preferable that the biomass should have a small and easily degradable lignin 
content. The composition of the plant from which the lignocellulosic biomass is derived can also 
be subjected to modification by means of genetic engineering [149]. The main sugar constituents 
of lignocellulosic biomass (Figure 1) are glucose and xylose, while arabinose, galactose and 
mannose are also present in smaller quantities. 
 
FIGURE  1 A schematic presentation of lignocellulose utilization in bioprocesses. Examples of the prod-
ucts and lignocellulose components (in parentheses) are given below each phase. 
Lignocellulosic biomass has to be pretreated prior to fermentation in order to release the fer-
mentable sugars [68]. The pretreatment methods can be divided into acid-based methods, mild 
alkaline methods, oxidative methods, hydrothermal processing, chemical pulping processes, and 
2 Background 
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the use of alternative solvents [85]. These methods aim at hydrolysing or solubilizing hemicellu-
lose or removing lignin. Acid-based methods include a promising method, acid hydrolysis. In this 
process, the lignocellulosic biomass is treated with mineral acids, organic acids or sulfur dioxide. 
In hydrothermal processing, liquid water or water vapor at high pressure are used.  Alkaline 
pretreatments with mild alkali are less efficient but also produce less inhibitors than acid pretreat-
ment or hydrothermal processing. The oxidative methods aim at using oxidants to separate the 
cellulose and hemicellulose from the lignin and to decrystallize the cellulose. In chemical pulping, 
cellulose can be separated from hemicellulose and lignin, which are converted to liquors that can 
be used for energy production or fermentation by, for example,e S. cerevisiae. In an alternative 
solvent pretreatment, the lignocellulose components can be separated by disrupting their non-
covalent interactions without significant inhibitor formation. However, the collection of hemicellu-
lose and lignin fractions must be improved before this method can be used industrially. 
The hydrolysis of the lignocellulosic biomass yields inhibitors in varying amounts and depends 
on the source of the biomass and the pretreatment methods [179]. Different inhibitors are derived 
from different lignocellulose components [85]. Hexose sugars can be degraded to 5-HMF and 
pentose sugars to furfural. 5-HMF and furfural can be further degraded into levulinate and formic 
acid, respectively. The aromatic inhibitors like 4-HB are derived from lignin, while acetate is de-
rived from hemicellulose. The presence of the inhibitors can usually be considered harmful to the 
bioprocesses [84], but they can also be beneficial. For example, 3.3 g/l of a protonated form of 
acetate was shown to increase the ethanol (EtOH) yield of S. cerevisiae by 20 % [180]. However, 
when the protonated form of acetic acid was higher than 5 g/l the growth of S. cerevisiae was 
inhibited [180]. When cultivated on xylose the acetate tolerance of S. cerevisiae has been shown 
to be lower than when cultivated on glucose, which was considered to be due to the lower fer-
mentation rate of xylose [66]. The presence of acetate in the growth medium increases toxicity 
of furfural to S. cerevisiae [138] and E. coli [206]. Also, acetate appears to be more toxic to E. 
coli growing on glucose in a minimal medium [126] than in a rich medium [102]. Thus it can be 
said that, while acetate is not very inhibitory in itself, it might be worthwhile to remove it from the 
lignocellulosic hydrolysates with techniques like biodetoxification (see below), if inhibitors like 
furfural are also present. Alternatively, tolerance of the host organism towards this organic acid 
might be improved by adaptation or metabolic engineering. 
The presence of lignocellulosic inhibitors and the sequential use of the sugars have been con-
sidered as one of the biggest problems in the production of second generation biofuels [191]. 
Most of the experiments carried out for this thesis were done using individual components of the 
lignocellulosic hydrolysates, or a combination of these components, as carbon source. While 
experiments carried out with actual lignocellulosic hydrolysates would have unarguably produced 
data more relevant to real-life applications, using individual components in a synthetic medium 
produces results that can be generalized more easily. One experiment was, however, carried out 
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with enzymatically hydrolysated rice straw (Publication II), in order to show that the genetic mod-
ifications work with actual lignocellulosic hydrolysates. Glucose was used in all publications of 
this thesis because it is often the most abundant carbon source found in lignocellulosic hydroly-
sates. Although not the most severe inhibitor of lignocellulosic hydrolysates, 4-hydroxybenzoate 
(4-HB) was used as a model compound of aromatic inhibitors due to its abundance in many 
lignocellulosic hydrolysates [139]. 
The host organism using lignocellulosic hydrolysates should be capable of catabolizing all the 
carbon sources present in this raw material in order to maximize the product yield. This is espe-
cially important in bioprocesses where products like biofuels, which are of lower value, are pro-
duced. If the host organism is capable of catabolizing multiple carbon sources present in the raw 
material, it would be of advantage if these would be consumed simultaneously because this 
shortens the bioprocess running time [94]. However, in their natural environment, microorgan-
isms often benefit from sequential usage of the carbon sources. This allows them to consume 
the best carbon source first, so that the competing microorganisms do not consume it before 
them. The carbon catabolite repression of xylose and arabinose consumption by E. coli has been 
particularly well characterized [32]. In the presence of glucose, arabinose and xylose, E. coli 
consumes first glucose, then arabinose and only then xylose [32]. In this example, glucose pre-
vents the catabolism of both arabinose and xylose, and arabinose prevents the catabolism of 
xylose. When catabolite repression occurs in this way in multiple layers, the metabolic engineer-
ing of a strain that consumes the sugars simultaneously becomes more difficult. An alternative 
to engineering the metabolism of the host organism for simultaneous consumption of all carbon 
sources is to engineer different strains of the host organism for consumption of only one carbon 
source, and then use them in a mixed culture. This approach has been shown to be successful 
in the consumption of glucose, arabinose and xylose simultaneously with three different strains 
of E. coli C [201]. The simultaneous use of glucose and xylose, which would have otherwise 
been consumed sequentially, has been achieved by encapsulating S. cerevisiae [191]. The sim-
ultaneous utilization of the carbon sources was caused by a gradient of glucose in the encapsu-
lated cell mass, and the low glucose concentration in the middle of the cell mass allowed xylose 
consumption [191]. 
2.1.1 Biodetoxification of lignocellulosic hydrolysates 
There are a large variety of techniques for removing the inhibitors produced in hydrolysis of lig-
nocellulosic biomass. These techniques differ greatly in their abilities to remove the inhibitors 
without decreasing the sugar content of the hydrolysate, their physical characteristics, and in 
their cost. These techniques can be divided into physical, chemical and biological methods [84]. 
Biodetoxification, which is one of the biological methods, is generally slower than the physical or 
chemical methods but requires less energy and does not produce so much waste water [35]. 
Another advantage of using biodetoxification is that, unlike with physico-chemical methods, the 
carbon of the inhibitory molecules is not lost in the process but can be used in the synthesis of 
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other valuable molecules as a side-stream of the actual fermentation where the detoxified ligno-
cellulosic hydrolysate is used as raw material. As biodetoxification competes with other, more 
robust detoxification methods, it might be necessary to produce these valuable compounds with 
the biodetoxification strain in order to make biodetoxification economically feasible. If the biode-
toxification organism could also perform other functions, such as the production of cellulases or 
the removal of oxygen for anaerobic host organisms, this detoxification method might become a 
more attractive alternative. 
Biodetoxification can be carried out by isolating microorganisms capable of using the lignocellu-
losic inhibitors as a carbon source but which do not consume the lignocellulosic sugars [195], or 
engineering such organisms from model organisms by knocking out the genes for sugar catab-
olism [100]. The tolerance of the host organism towards the inhibitors can also be achieved by 
engineering the metabolic steps involved in inhibitor tolerance [194]. Many organisms in nature 
are capable of growing on lignocellulosic inhibitors [58], [76], [196] and the genes for these func-
tions can be cloned from them. ADP1 can grow on many organic acids but cannot grow on any 
other sugar than glucose as a sole carbon source. This creates an opportunity to convert ADP1 
into a detoxification strain that consumes only the organic acids, which can be growth-inhibitory 
to the bioprocess host microorganisms. 
2.2 Growth rate 
Bioprocesses benefit from a high growth rate in the host organism as long as the increased 
growth rate does not decrease product formation, as this reduces the time needed to run the 
bioprocess. This applies especially when lower value chemicals are produced. Thus, if other 
parameters remain unchanged, an increase in the growth rate of the host organism is a goal 
worth striving for. Bacterial growth can be divided into a lag phase, an acceleration phase, an 
exponential phase, a retardation phase, a stationary phase, and a phase of decline [122]. The 
most important phase with respect to WE production by A. baylyi is the stationary phase (when 
growth is not limited by carbon) as WEs are synthesized most efficiently then [56]. Thus, in order 
to increase the WE productivity of ADP1, shortening the lag and exponential growth phases can 
be considered important. The lag phase has traditionally been considered to be due to the ad-
aptation of the metabolism of all the cells in the population to the presence of the carbon source 
by synthesis of catabolic enzymes [122]. More recently, it has become evident that the lag phase 
is also affected by the fact that only a part of the population of the cells present initially in the 
growth medium start to grow, while the rest of the cells do not grow at all during the cultivation. 
This has been shown to occur with E. coli K12 BW25113 after the carbon source is changed 
from glycolytic to gluconeogenic [98]. The proportion of the cells starting to grow on a gluconeo-
genic carbon source depends on the gluconeogenic flux after the change in the carbon source 
and could be affected by increasing the uptake of the gluconeogenic substrate [98]. If this is the 
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case, the lag phase could be reduced through metabolic engineering by increasing the carbon 
source uptake rate. When ADP1 is cultivated on glucose as a sole carbon source, a significant 
lag phase is caused by the fact that ADP1 has to convert glucose to gluconate prior to further 
catabolism [188]. This lag phase could be shortened by increasing the activity or availability of 
glucose dehydrogenase (GDH), which is responsible for this oxidation reaction [188] or by in-
creasing the amount of the inoculate (see Figure 4 in Publication I and Figure S5 in Publication 
III). However, it can be considered that the exponential growth phase is the most important de-
terminant of the total cultivation time in bioprocesses using ADP1 in WE production since it can-
not be increased by increasing the amount of inoculate. The exponential growth rate (μ) can be 
calculated as follows: 
 
where X1 is the number of cells at timepoint t1 and X2 the number of cells at timepoint t2. The 
exponential growth phase is the only phase of growth that can be reproducibly quantified [167]. 
Since the metabolic state of the bacterial cell, and thus the amount of the product formed from 
the substrate, is highly dependent on the growth state of the cell, it has been considered highly 
important to report exponential growth rates in the research articles [127]. This is especially true 
for experiments measuring WE production by ADP1, since it produces WEs at different rates in 
the exponential growth phase and in the stationary phase [56] and a small difference in the stage 
of growth might have dramatic effects on the WE yields. Because of this, the experiments pre-
sented in this thesis that involve comparison of WE production by metabolically engineered 
strains with wild type (WT) ADP1 have been carried out in the exponential growth phase and the 
samples have been taken at time points where similar amounts of the substrate have been con-
sumed. 
The growth rate of a bacterium depends on the carbon source, and some carbon sources allow 
faster growth than others [111]. A generalization has been made that the metabolism of ADP1 is 
geared towards the catabolism of carbon sources that enter its metabolism as intermediates of 
the tricarboxylic acid (TCA) cycle, but it works less well on carbon sources that are processed 
via glycolysis [12], [204]. This is in contrast to E. coli, which grows faster on carbon sources that 
are processed via glycolysis than carbon sources that enter directly from the TCA cycle [7]. 
These characteristics can be influenced by means of metabolic engineering. The growth rate of 
E. coli on pyruvate and succinate has been improved by increasing the expression levels of 
phosphoenolpyruvate (PEP) synthase (pps) and PEP carboxykinase (pck) genes, respectively 
[23]. The authors concluded that at least in the improvement of growth rate on pyruvate by over-
expression of pps, the improved growth has to be due to the enhanced synthesis of key biosyn-
thetic metabolites, rather than improved energy production [23]. Another example is the improved 
growth rate of Gluconobacter oxydans on glucose after knocking out the genes responsible for 
the formation of gluconate from glucose [99]. This improvement, however, resulted in acetate 
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formation [99]. The growth rate of ADP1 on glucose has already been improved by supplement-
ing the cells with extra pyrrolo-quinoline quinone (PQQ) (see Sugar metabolism) [188]. 
2.3 Biomass yield 
The amount of bacterial cells in a growth medium can be determined by estimating the number 
of the cells or measuring the dry weight of the bacterial biomass [122]. However, it has been 
known for a century that the size and shape of a bacterial cell may change during different phases 
of growth [67] and thus the measured biomass values do not necessarily reflect the number of 
cells present in the cultivation. Since the titer and purity of the intracellularly accumulating WEs 
depend on the final biomass obtained, not on the number of the cells, determination of the bac-
terial numbers in the cultivations is not discussed here. 
In order to be economically feasible, bioprocesses usually have to allow the cells to grow to a 
high cell density [155]. This is especially true in the case of products that have lower economic 
value [192], but bioprocesses where more valuable products are produced also benefit if the cells 
grow to a high density [174]. This is because the increased cell density allows the use of smaller 
fermentors and downstream processing equipment like centrifuges, and less materials such as 
purified water [174]. The density of bacterial cells in a growth medium is limited by the fact that 
at a certain point the medium loses its fluidity [104]. The viscosity of E. coli B increases rapidly 
when cell densities above 200 g/l are reached, and the medium loses fluidity at 220 g/l [124]. 
Thus, it can be said that the maximum cell density that can be obtained in bioreactors with this 
bacterium is around 220 g/l [124]. Often, however, other problems start to limit the growth of 
bacteria before this upper limit has been achieved. Some nutrient might start to limit the growth, 
or the production of inhibiting metabolites might be triggered [174]. Many nutrients inhibit growth 
at high concentrations, which is why batch cultivations are not for the best approach to achieving 
high cell density. A major problem encountered when growing microorganisms to high cell den-
sity is the accumulation of growth-inhibiting side products, for example acetate with E. coli [174]. 
This problem can be prevented by modifying the growth conditions (e.g. by limiting the amount 
of the carbon source in the growth medium) or by metabolic engineering [174]. 
Some bacteria secrete signalling molecules that, when accumulated to a threshold concentration, 
induce a physiological change in the cell population. This phenomenon, which is often observed 
at elevated cell densities, is referred to as quorum sensing [110]. Since WE-producing biopro-
cesses using ADP1 as a host organism should preferably produce high cell density, the possible 
effects of quorum sensing on the metabolism of ADP1 might become relevant. ADP1 has been 
shown to produce four quorum-sensing molecules in a minimal medium, produced mainly in the 
stationary phase [63]. It has been suggested that quorum sensing controls the efficient utilization 
of extracellular molecules produced by the bacteria, and that the cell density does not affect how 
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beneficial it is to produce intracellular molecules [28]. Quorum sensing has also been thought to 
improve stress tolerance in high cell density cultivations [192]. However, since the functions of 
these molecules are unknown, it cannot be speculated how they might affect WE production or 
the biomass accumulation by ADP1. 
2.4 Metabolic engineering 
Since 1991, the sub-discipline of genetic engineering that involves the manipulation of metabolic 
pathways has been referred to as metabolic engineering [11]. Systems metabolic engineering 
uses the methods of systems biology and ‘omics’ technologies to achieve more complete control 
over metabolism [103]. The Meta-Council on Emerging Technologies of the World Economic 
Forum acknowledged systems metabolic engineering as one of the top 10 emerging technolo-
gies of 2016 [198]. As an environmentally friendly alternative to fossil fuels, metabolically engi-
neered organisms are used in biofuel production from renewable sources [148]. However, as 
noted in the report [198], production by metabolically engineered organisms might be more suit-
able than chemical synthesis from petrochemicals when the products are complex organic mol-
ecules. One group of complex organic compounds that might more feasibly be produced with 
metabolically engineered organisms, rather than with synthetic chemistry, are active pharmaceu-
tical ingredients, which have been divided by Keasling into three categories: alkaloids, polyke-
tides and isoprenoids [93]. Such compounds are currently extracted from natural sources be-
cause their chemical synthesis would be very complicated and expensive. Furthermore, unlike 
in chemical synthesis where waste material is produced, bioprocesses using metabolically engi-
neered microorganisms can use waste materials from other industries as a raw material. These 
waste materials include lignocellulosic biomass from, for example, agricultural industries. How-
ever, metabolically engineered organisms are not suitable for the production of chemicals that 
are toxic to the host organism, and the metabolism of the host organisms limits the range of 
chemicals that can be produced [93]. 
Metabolic engineering is often used to optimize the flow of carbon from the growth substrates to 
the product formation. This means that the optimal bioprocess host organism has a metabolism 
that converts the raw material as fast as possible, with as high a yield as possible, to as high a 
titer as possible. Product yield and purity can be improved by eliminating pathways that result in 
the formation of side-products, such as acetate with E. coli [140] or exopolysaccharides (EPS) 
with ADP1 (see Results and Discussion). On the other hand, the addition of anabolic steps or 
complete pathways allows the formation of products that the organism does not naturally produce, 
and the incorporation of catabolic pathways allows broadening of the carbon source range used. 
The addition of anabolic pathways can be used to tailor the product to better meet the require-
ments of a given application, or for the production of compounds that do not occur naturally in 
the microorganisms. The addition of catabolic pathways can be used to allow more complete 
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utilization of complex raw materials such as lignocellulosic hydrolysates. Metabolic engineering 
can also be used in improving the tolerance of the host organism towards toxic products, such 
as solvents. 
Although a lot of knowledge has been gained about engineering the metabolism of microorgan-
isms over recent decades, not much about the engineering principles has been drawn from this 
research. As Yadav et al. have noted, most research has merely produced demonstrations of 
how the technology could be applied [203]. A lot of research has concentrated on engineering 
the central carbon metabolism, which refers to the uptake and oxidation of the metabolites and 
includes pathways such as glycolysis, gluconeogenesis, the pentose phosphate pathway (PPP), 
and the TCA cycle [142]. These pathways produce precursors for the anabolic pathways involved 
in the synthesis of most of the products produced in bioprocesses. It is generally accepted that 
all of the metabolites produced by microorganisms can be formed from 12 precursor metabolites 
[132]. Since these precursors are part of multiple metabolic pathways, modifications that affect 
one pathway inevitably also affect other pathways [129]. Thus, by modifying these pathways, it 
is possible to optimize the capability of the host organism to produce the wanted product. All of 
the metabolic engineering carried out in this thesis involves the central carbon metabolism by 
affecting glycolysis (Publication II), PEP-pyruvate-oxaloacetate node (Publication I), acetate pro-
duction (Publication IV), or gluconeogenesis (Publication III). The modifications carried out in 
Publications I, III and IV aim to maximize the amount of the WE synthesis precursor, acetyl-
coenzyme A (acetyl-CoA), by modifying the central carbon metabolism of ADP1, while the mod-
ification carried out in Publication II completely eliminates the sugar metabolism. 
The PEP-pyruvate-oxaloacetate node of E. coli has been much studied [165] and engineered 
[107], but the PEP-pyruvate-oxaloacetate node of ADP1 has been studied only by Elbahloul & 
Steinbüchel, who overexpressed its gene for PEP carboxylase, although this did not affect the 
growth rate on gluconate [43]. As noted by Nielsen & Keasling, once the central carbon metab-
olism has been optimized for production of a precursor metabolite for some product, this strain 
can be easily engineered to produce other metabolites using the same precursor [131]. Thus, 
the metabolic engineering work carried out for this thesis, that is engineering central carbon me-
tabolism of ADP1 for WE synthesis, might also be of use when other metabolites are produced 
from the precursor molecule acetyl-CoA. Engineering the central carbon metabolism might also 
be used to improve the growth characteristics of the host organism, which is especially important 
when producing WEs with ADP1, since this bacterium produces WEs mainly in the lag phase 
and the final WE titer is limited by the dry cell weight (DCW) obtained (see Wax ester synthesis). 
The growth rate can be improved by, for example, adding new metabolic steps, as is shown in 
this thesis (Publication I), or by affecting the transcription factors that control the metabolic fluxes 
[130]. The presence of a plasmid burdens the cells [170] and thus higher product formation might 
be obtained by integrating heterologous genes to the host chromosome [203]. In this respect, 
ADP1 is an ideal host organism for metabolic engineering, since it readily incorporates foreign 
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DNA into its genome (see Natural transformation). Computational models for the metabolism of 
ADP1 have also been developed [39], which further makes this bacterium an attractive host or-
ganism for metabolic engineering. 
The host organism for metabolic engineering should have a suitable metabolism and physiology 
for production of the product molecule, and there should also be tools available for engineering 
the genome of the organism [93]. For example, the host organism used in this thesis, ADP1, is 
particularly suitable as a chassis in synthetic biology, as has been discussed by Santala [164]. 
ADP1 has a broad growth substrate range, is easy to cultivate and naturally produces large 
amounts of EPSs and WEs. Furthermore, ADP1 is naturally transformable, which makes genetic 
engineering of this organism very easy and not very time-consuming. Most biotechnological ap-
plications using ADP1 as a host organism harness it either as a host organism in bioprocesses 
or as a whole cell biosensor (see Biotechnological applications). When developing an efficient 
host organism in bioprocesses with metabolic engineering, it is important to be able to measure 
consumption of the raw materials and formation of the product (and possibly the side products). 
Traditionally, the concentrations of these metabolites have been measured with the methods of 
analytical chemistry, but more recently it has become possible to assess the efficiency of the 
host organisms using biosensors [123]. Biosensors can be used to measure concentrations of 
metabolic intermediates like long-chain aldehydes by producing light as an output [106]. This 
allows real-time measurement of the intracellular metabolite, which is infeasible with the methods 
of analytical chemistry. The analytical chemistry methods are often more laborious and time-
consuming than methods based on biosensors, and biosensors also tend to have higher through-
put. 
Synthetic biology is the most advanced form of genetic engineering and differs from the other 
sub-disciplines mainly due to the high level of standardization, which makes it much easier to 
design and build new genetic constructs [46]. Synthetic biology is considered to be able to pro-
duce solutions to the problems encountered in bioprocesses using more recalcitrant raw materi-
als [59]. Synthetic biology and metabolic engineering partially overlap, but while metabolic engi-
neering is involved mostly in improving existing metabolic pathways or adding few metabolic 
steps or pathways to the host organism, synthetic biology allows the construction of completely 
new pathways in microorganisms devoted to the formation of the product [131]. Furthermore, the 
production of efficient host organisms for bioprocesses benefits from both disciplines, since the 
novel metabolic pathways constructed with synthetic biology can be optimized with metabolic 
engineering [131]. In addition, the central carbon metabolism might not be geared towards syn-
thesis of a novel compound whose production is possible with synthetic biology, and metabolic 
engineering can be used to fix this [131]. Synthetic biology has experienced rapid progress in 
the last few decades and is currently moving towards increasingly complex applications, such as 
E. coli capable of reacting to light with different wavelengths [51], and to higher organisms [144]. 
Synthetic biology has also allowed the engineering of metabolic pathways for opioid production 
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in yeast [61] which has raised, in addition to hopes, concerns about easier access to the drug by 
the public [40]. Traditionally, genetic engineering has been performed using multiple cloning sites 
containing restriction digestion sites for the numerous restriction endonucleases. In synthetic 
biology, construction of the genetic constructs is standardized, so that only a limited number of 
restriction enzymes are used, which greatly simplifies the design of the constructs. Also, the need 
to eliminate restriction enzyme recognition sites from the inserts is reduced by the fact that not 
so many enzymes are used in the construction. Synthetic biology allows automatization of the 
engineering of microorganisms, which makes producing applications more economically feasible 
[65]. 
Some prokaryotic species possess an adaptive immune system called clustered regularly inter-
spaced short palindromic repeats (CRISPR)/CRISPR-associated proteins (Cas), which afford 
them protection against foreign DNA from viruses, for instance [25]. The immunological memory 
is stored in CRISPR arrays as spacers (~25-40 bp) which are located between the palindromic 
repeats (~21-40 bp). CRISPR/Cas systems-mediated immunity starts with an adaptation phase 
during which the foreign DNA is sampled by Cas proteins and inserted into a CRISPR array as 
a new spacer. In the expression phase, the whole CRISPR array is transcribed into precursor 
CRISPR RNA (pre-crRNA), which is then processed by Cas proteins and ribonucleases into 
crRNAs, which consist of a spacer and a single repeat. Effector CRISPR ribonucleoprotein com-
plexes (crRNP) are then formed, in which the crRNAs are then bound by Cas proteins and other 
CRISPR/Cas components. In the interference phase, the cRNP complexes use the crRNAs to 
identify the target DNA, which will be degraded. 
In addition to being a breakthrough discovery in microbiology, CRISPR/Cas systems have also 
been harnessed in genetic engineering [25]. CRISPR/Cas systems can be used to accurately 
modify and study the genomes of prokaryotic and eukaryotic species more cheaply and more 
quickly than be done with traditional methods. While most research on the applications of 
CRISPR/Cas has been carried out with eukaryotes, some applications on prokaryotic organisms 
have also been developed. The existence of numerous efficient tools for genetic engineering in 
many prokaryotes might be the reason for the relatively greater interest in applying CRISPR/Cas 
on eukaryotes. CRISPR/Cas, however, allows prokaryotes to be engineered even if there are no 
efficient genetic engineering tools available. Most bacteria cannot repair the double-stranded 
breaks generated by CRISPR/Cas by non-homologous end joining, so they require a template 
for homology-directed repair. This template can be used to generate desired modifications to the 
genome. While the genome of APD1 can be engineered with great ease and there are good tools 
for this, the KOs carried out in Publications II-IV were produced with a KO cassette containing 
an antibiotic resistance selection marker. Since there are only a limited number of such selection 
markers for any given host organism, the generation of a large number of gene KOs would re-
quire the use of markerless deletion of the genes, which could be achieved with, for example, 
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CRISPR/Cas techniques. This would also allow more sophisticated integration of foreign genes 
into the genome of ADP1. 
2.5 Acinetobacter baylyi ADP1 
Research on A. baylyi ADP1 (Table 1) began in 1960 when Taylor & Juni isolated its parental 
strain, BD4, from soil by using meso-2,3-butanediol as a sole carbon source in a minimal medium 
[181]. The strain was characterized as a Gram-negative aerobe, which grows in liquid media 
either alone or as pairs or short chains of rods which are heavily encapsulated by EPSs [181]. 
BD4 was characterized as non-motile [181] but later research has shown that the strain ADP1 
can move on surfaces by twitching, and that it is inhibited by exposure to blue light [15]. In sub-
sequent research, the central metabolism [182] and EPS capsule synthesis [183], [81] were stud-
ied. Juni & Janik used BD4 in an experiment to elucidate the intermediates of the EPS capsule 
synthesis, where unencapsulated mutants, which had different EPS capsule synthesis genes 
disrupted by mutations, were grown together [82]. The authors noticed that this resulted in the 
formation of stably-encapsulated strains which was shown to be due to the genetic transfor-
mation of the intact gene from one mutant strain into another, which had a different EPS capsule 
synthesis gene disrupted than the donor strain. In this study BD4 was subjected to UV mutagen-
esis and a strain was isolated, along with many unencapsulated strains, that produced a small 
EPS capsule. This strain was referred to as BD413, and is currently known as ADP1. This strain 
has been referred to as A. calcoaceticus (see for example [91]) but has later been shown to 
belong to the species A. baylyi [189]. Another less-frequently used name for the strain is A. cal-
coaceticus LMD 82.3 [188]. The genetic difference between BD4 and ADP1 has not been eluci-
dated, and phenotypic differences between the strains have been studied only by comparing 
their EPS production [91]. The main difference between the strains in this respect is that, while 
most of the EPS produced by BD4 remain on the cell surface as a large capsule, ADP1 excretes 
half of the EPS it produces to the growth medium and also produces less EPS than the parental 
strain BD4 [91]. This difference causes ADP1 to form much denser pellets in centrifugation, which 
makes it easier to study this bacterium [80]. Since the initial studies by Juni & Janik [82], ADP1 
has become an important model organism for transformation [204] and metabolism studies [204], 
[29], while most of the studies about the EPS capsule have been carried out with the parental 
strain BD4 [17], [91], [90], [92], [135]. While most of the early research with ADP1 focused on 
natural transformation, more recently its versatile metabolism has also attracted a lot of attention. 
In particular, the catabolism of aromatic compounds, and the complex regulatory networks gov-
erning these pathways, have been studied extensively [204]. These studies have elucidated so-
phisticated mechanisms of gene expression and biochemistry of aromatic compounds [16]. How-
ever, glycolysis, pyruvate metabolism and EPS metabolism, the metabolic pathways studied in 
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this thesis, have not been studied so extensively with ADP1. The development of metabolic en-
gineering and synthetic biology have enabled the engineering of ADP1 as a host organism for 
various biotechnological applications [45]. These applications include production of valuable 
chemicals [43] and biosensing [106]. 
TABLE 1  Taxonomy of A. baylyi ADP1. 
Domain Bacteria 
Phylum Proteobacteria 
Class Gammaproteobacteria 
Order Pseudomonadales 
Family Moraxellaceae 
Genus Acinetobacter 
Species Baylyi 
Strain ADP1 
2.5.1 Genetics 
The genome of ADP1 is relatively small (3 598 621 bp and 3325 predicted coding sequences) 
and has a G+C content of 40.3 % [12]. The single-gene KO mutant study by de Berardinis et al. 
indicated that 499 of these 3325 genes might be essential [30]. Approximately one fifth of the 
genome has been estimated to code for genes involved in catabolism, and these genes are 
arranged in five clusters referred to as "islands of catabolic diversity" [12]. ADP1, however, lacks 
genes for the following enzymes that are part of the central metabolism in most organisms: glu-
cokinase (and hexokinase and a glucose transporter phosphotransferase system), 6-phos-
phofructokinase, pyruvate kinase, glucose-6-phosphate dehydrogenase, and 6-phosphogluco-
nolactonase [12]. The lack of, for example, a pyruvate kinase gene is also shared with closely 
related A. baumannii strains [185]. ADP1, however, does have genes for the catabolism of glu-
cose via the Entner-Doudoroff (ED) pathway [12]. The lack of several genes for enzymes of 
Embden-Meyerhoff-Parnass (EMP) glycolysis complicates metabolic engineering efforts to allow 
the ADP1 to catabolise sugars other than glucose. For example, the phosphorylative catabolism 
of xylose or arabinose results in the production of fructose-6P and glyceraldehyde-3P, both of 
which would need to be processed via EMP glycolysis in order to be completely oxidized. 
The genome of ADP1 contains two prophages of 53 kb and 9 kb [12]. The 9-kb prophage can be 
activated in cultivations of ADP1 and its emergence reduces the growth and natural transfor-
mation capability of ADP1 [153]. This phage uses the natural transformation machinery of ADP1 
to infect the cells and therefore cannot infect cells whose natural-transformation genes have 
been knocked out [153]. The authors suggested that the reduced transformability was due to the 
selection of phage-resistant cells [153]. In the laboratory evolution experiment by Renda et al. 
49 kb of the larger prophage region was lost in all sequenced clones under conditions allowing 
adaptive evolution, but none was lost in clones of the mutation accumulation cultivations [154]. 
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This suggests that deletion of this region from the genome of ADP1 increases the fitness of the 
strain [154]. Suárez et al. have removed all six transposon IS1236 sequences from the genome 
of ADP1 and found out that this strain accumulated mutations that inactivated the reporter gene 
7 to 21 times less often [178]. This strain also had an improved ability for natural transformation, 
underwent autolysis to a smaller degree, had a shorter lag phase and grew to a higher optical 
density [178]. As the authors of the above-mentioned study suggested [178], this strain is much 
more suitable as a host organism in metabolic engineering than the WT ADP1. 
2.5.1.1 Natural transformation 
Bacteria can acquire novel genes in a process called natural transformation [77]. In natural trans-
formation the bacterium actively takes up and integrates foreign DNA as a part of its physiology 
[77]. Thus, natural transformation differs from the other mechanisms of lateral gene transfer, 
conjugation and transduction, in the sense that the transfer of DNA is initiated by the recipient 
cell, not extrachromosomal genetic elements of the donor cell [77]. The ability of ADP1 to un-
dergo natural transformation was first described by Juni & Janik [82] and has since then been 
studied intensively [9], [113]. The exceptional ability of ADP1 to undergo natural transformation 
is exemplified by the experiment of Palmen et al. where 25 % of a bacterial population was 
transformed with plasmid DNA [137]. The competence of ADP1 to undergo natural transfor-
mation has been shown to decrease in laboratory evolution experiments [9], [154]. Bacher et al. 
suggested that this might be due to the fact that the mutant alleles that do not allow the cells to 
be competent for transformation can be transferred to the competent cells, but the alleles allow-
ing competence for transformation cannot be transferred to the noncompetent cells [9]. However, 
Renda et al. have suggested that the activation of the prophage CRAϕ, which resides in the 
genome of ADP1, could drive the evolution of diminished transformability, since non-transform-
able mutants of ADP1 are completely resistant to this phage [153]. McLeman et al. have tested 
whether an ADP1 strain that is incapable of recombination of foreign DNA into its chromosome 
would have decreased evolvability to resistance to different phages. They found out that there 
was no difference between the recombigenic WT strain and the non-recombigenic drpA mutant 
strain [113]. 
The competence of ADP1 for natural transformation is induced at the beginning of the exponen-
tial growth phase and lasts until the early stationary phase [137]. The competence induction does 
not depend on the carbon source used, nor on whether a minimal or rich medium is used, but 
the medium must contain divalent cations (Mg2+, Mn2+, Ca2+) in order for transformation to occur 
[137]. Competence induction is also not affected by the acidity of the growth medium, although 
the transformation frequency is lower in an acidic (pH below 6.5) medium [137]. Transformation 
frequency is also dependent on the DNA homology, the genomic location of the insertion [150] 
and the type of DNA and selection marker used [137]. Plasmid DNA that contains an insertion 
cassette can integrate into the chromosome of ADP1 by replacement recombination, where the 
cassette replaces the DNA sequence corresponding to the flanking regions used in the cassette, 
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or by integration of the whole plasmid into the chromosome [137]. While the former has been 
shown to occur much more frequently [137], the KO cassette amplified with PCR was used in 
transformations carried out for the publications of this thesis in order to eliminate the possibility 
of obtaining the latter type of transformants. Transformation frequency increases with increasing 
concentrations of DNA up to a limit, after which a maximum frequency is reached [137]. Increas-
ing the cultivation time in the presence of the transforming DNA also increases the transformation 
frequency, but a plateau at which the transformation frequency stops increasing is reached after 
a few hours of cultivation [137]. Culture supernatants of ADP1 contain extracellular DNA, but it 
has been shown that this DNA is not actively excreted but is liberated by lysis of the cells [136]. 
Bacher et al. have shown that ADP1 and its non-competent com mutant grow slower in the pres-
ence of extracellular DNA [9]. 
2.5.2 Metabolism 
ADP1 is known as a nutritionally versatile bacterium and it can catabolize a wide variety of plant-
derived carbon sources, such as aliphatic and aromatic acids [204], [53], a trait found also in 
other A. baylyi strains [52]. Utilization of glucose as a source of carbon and energy is relatively 
rare among Acinetobacter strains [83]. Glucose is metabolized via modified ED glycolysis [48]. 
ED glycolysis produces one molecule of adenosine triphosphate (ATP) per glucose catabolized, 
while EMP glycolysis produces two molecules of ATP per catabolized glucose [57]. In ADP1, no 
ATP is produced due to lack of pyruvate kinase (see Sugar metabolism). ED glycolysis, however, 
requires less protein and might thus be a more optimal glycolytic strategy for aerobic organisms 
like ADP1, i.e. those that do not live under energy-deprived conditions [57]. ED glycolysis is 
thermodynamically more favourable than EMP glycolysis, if the total change in the Gibbs ener-
gies of all the reactions are compared [57]. 
2.5.2.1 Sugar metabolism 
Glucose is the only sugar that is known to be able to support the growth of ADP1 as a sole carbon 
source [181]. Other sugars present in cellulosic biomass, such as xylose and galactose, can be 
oxidized partially to their corresponding lactones by GDH, which then hydrolyze to sugar acids 
at an elevated pH [187]. This process provides the bacterium with energy and allows the cells to 
grow to higher biomass in cultivations that are limited by carbon [187]. Enzymatic activities for 
glucose and gluconate oxidation can only be detected in cells grown on glucose, and not in cells 
grown on acetate or EtOH [182]. However, when acetate-grown cells are transferred to a medium 
containing glucose, they are able to produce gluconate but do not further catabolize it [188]. The 
data presented in Publication IV also indicate that the presence of 2.7 g/l of acetate, but not 1.1 
g/l of EtOH, represses glucose catabolism. Thus, it seems that the genes for the production of 
gluconate from glucose are constitutively expressed, but the genes for gluconate catabolism are 
only expressed when glucose, but not acetate, is present in the growth medium. 
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The catabolism of glucose (Figure 2) begins with its oxidation to gluconolactone by GDH. A. 
baylyi has GDH in both soluble and membrane-bound forms [37] but it appears that only the 
membrane-bound form of GDH is active in glucose oxidation [13]. GDH has PQQ as a prosthetic 
group [38]. The electrons derived from glucose oxidation are funneled from GDH to cytochrome 
b via ubiquinone [13] and can be used in the production of ATP and the transport of amino acids 
into the cell [186]. Gluconolactone is converted by gluconolactonase to gluconate, but this reac-
tion also occurs also spontaneously at pH 7.0 [187]. Gluconate formation results in the production 
of H+, and thus a decrease in the pH of the growth medium will always occur when glucose is 
used as the sole carbon source in cultivations of ADP1. Gluconate formation from glucose ap-
pears to be pH-dependent, at least in A. calcoaceticus LMD 79.41, and does not proceed at pH 
5.0 [187]. Thus, if the pH is not controlled, the decrease in pH caused by gluconate formation 
might start to limit the glucose catabolism. Gluconate is imported to the cytoplasm where its 
carbon 6 is phosphorylated, after which it is dehydrated and cleaved to pyruvate and glyceralde-
hyde-3P. ADP1 can use pyruvate for the production of ATP, biomass precursors in the TCA cycle 
or in gluconeogenesis. Glyceraldehyde-3P, on the other hand, cannot be funneled directly into 
TCA, but has to be converted first to PEP, which is then carboxylated to oxaloacetate. Oxalo-
acetate can then be converted to malate, which can be decarboxylated to pyruvate [34]. Dolin 
and Juni have proposed that ADP1 could use this pathway to circumvent the lack of pyruvate 
kinase [34]. The direct formation of pyruvate from PEP by pyruvate kinase results in the formation 
of one molecule of ATP, while pyruvate formation via oxaloacetate and malate does not result in 
any synthesis of ATP, or of the other energy carrier molecules (orthophosphate is produced in-
stead of ATP). Glyceraldehyde-3P can be used in gluconeogenesis, which produces precursors 
for EPS synthesis [183]. 
It has been suggested that glucose catabolism in ADP1 might involve recycling the glyceralde-
hyde-3P to 6P-gluconate via a 6P-glucose intermediate [204]. However, BD4 (the parental strain 
of ADP1) does not have glucose-6P dehydrogenase activity [182]. Furthermore, a radiolabelling 
study has shown that practically all glyceraldehyde-3P (but not pyruvate) formed from glucose is 
used in EPS synthesis in the strain BD4 [183]. If there is carbon recycling to 6-phosphogluconate, 
the carbon flux through the recycling pathway is probably relatively small. The unencapsulated 
mutants of A. baylyi lyse when grown on glucose as a sole carbon source, and it has been sug-
gested that this is due to the lack of pyruvate kinase activity in the cell [182]. The EPS negative 
mutant would not be able to funnel all the glyceraldehyde-3P produced from glucose to pyruvate 
via the TCA cycle, because CO2 might be present in a limiting concentration [182]. 
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FIGURE  2  Metabolic reactions and pathways of A. baylyi ADP1 relevant to this thesis. Irreversible re-
actions are marked with single-headed arrows and reversible reactions are marked with 
two-headed arrows. The crossed arrows indicate reactions which were eliminated by gene 
KOs. The arrows going through boxes indicate that the product is formed in the pathway 
written in the box. The genes (or their identifiers if names are unavailable) coding for the 
enzymes catalyzing the reactions are shown next to the arrows. The WE catabolic pathway 
has not been characterized and the arrows marked with question marks indicate reactions 
potentially involved in WE catabolism. 
19 
 
2.5.2.2 Exopolysaccharide metabolism 
A. baylyi strains produce EPS (Figure 3) capsules which protect the cells from desiccation [135] 
and prevent them from forming aggregates [81]. The EPS of BD4 and ADP1 also acts as an 
emulsifier, but requires a protein component for this function [92]. It has been shown that the 
outer membrane protein OmpA is secreted in ADP1, and that this protein possesses emulsifying 
activity [193]. 
 
FIGURE  3 A simplified structure of the repeating unit of the EPS produced by A. baylyi BD4 and ADP1. 
Adapted from the more detailed structure determined by Kaplan et al. [90]. 
BD4 produces EPS at a constant rate (4 mg/h/g of DCW) throughout its growth on succinate [17]. 
The composition of the EPS produced in this way (rhamnose/glucose/mannose, 4:2:1) does not 
change much during growth on this carbon source [17]. However, when the carbon source is 
changed to glutamate or EtOH, the composition changes slightly (rhamnose/glucose/mannose, 
10:5:1) [17]. When BD4 is cultivated on glucose, the composition differs from the above-men-
tioned values (rhamnose/glucose/glucuronic acid/mannose, 4:1:1:1) [90]. In the article by Kaplan 
et al. [90], it was shown that the glucuronic acid can be converted to glucose, and it could be that 
the glucose fraction in the studies by Bryan et al. [17] also contains glucuronic acid. Regardless 
of the carbon source or the analysis methods used, rhamnose is the most abundant EPS com-
ponent, glucose (and glucoronic acid) is the second most abundant, and the least abundant is 
mannose. The synthesis of EPS starts with activation of the gluconeogenically produced sugars. 
The rhamnose, glucose and the glucuronic acid components of EPS are produced from glucose-
1P, while the mannose component is produced from fructose-6P (Figure 2). All of these activated 
sugars are thus produced from metabolites that cannot be converted to metabolites of the "lower" 
part of the gluconeogenic pathway, since ADP1 cannot phosphorylate fructose-6P to fructose-
1,6P (Figure 2). 
A laboratory evolution experiment by Renda et al. showed that increased cellular aggregation 
due to deletion of EPS synthesis-related genes occurred more frequently under high selective 
pressure than under reduced selective pressure [154]. Thus, it appears that, at least when grown 
in a rich medium, the presence of an EPS capsule (and/or excreted EPS) does not confer selec-
tive advantage to the cells. Because of this, and also for the reasons explained below, it might 
be worthwhile to test how EPS-negative mutants of ADP1 behave in WE-producing bioprocesses. 
The mutations that eliminated EPS capsule synthesis in the experiment by Renda et al. [154] 
occurred in the genes-coding for perosamine synthase (per) or glucose-6P isomerase (pgi). The 
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latter of these genes codes for an enzyme that catalyzes the conversion of fructose-6P to glu-
cose-6P (Figure 2), which can then be converted to glucose-1P, a starting point for synthesis of 
three EPS components: glucose, glucuronic acid, and rhamnose. Thus, it seems that metabolites 
produced from glucose-6P are not essential to growth, at least in a rich medium. The fourth EPS 
component is synthesized from fructose-6P, which is also a metabolite used in PPP. Thus, it 
might be possible to prevent synthesis of all four EPS components with two gene KOs. However, 
it is uncertain whether glucose-1P is also used by ADP1 for other purposes, and thus it was 
considered a safer alternative to knock out the gene for first step in the synthesis of rhamnose, 
the main component of the EPS of ADP1, in order to produce the EPS negative mutant while 
only having a minimal effect on other metabolic functions. 
In a bioprocess where the components of lignocellulosic biomass are converted to WEs, the EPS 
capsule can be considered as an unwanted by-product, since the carbon used for its synthesis 
could have been used in WE synthesis. The EPS capsule might also lower the purity of the WE-
containing biomass and make it more difficult to collect the cells from the growth medium. Fur-
thermore, under the conditions encountered in the bioprocesses, protection against desiccation, 
a biological function of the EPS capsule, is not needed. Thus, it is likely that WE production might 
benefit from elimination of this trait from ADP1. It is, however, unclear how this would affect the 
survival of the cells and the metabolic flux toward WE synthesis. Another aspect to consider 
when studying the suitability of using an EPS synthesis-deficient strain of ADP1 in the above-
mentioned bioprocess is whether the capsule protects the cells from the growth inhibitors formed 
during hydrolysis of the lignocellulosic biomass. 
2.5.2.3 Acetate metabolism 
ADP1 can catabolize acetate via two pathways (Figure 2). Acetate can be phosphorylated by 
acetate kinase into acetyl-P, which is then converted to acetyl-CoA by phosphotransacetylase. 
Acetyl-CoA can also be formed directly from acetate by acetyl-CoA synthetase. The former path-
way converts ATP to ADP and P, and is reversible, while the latter pathway converts ATP to 
AMP and PP, and is irreversible.  
E. coli TG1 starts to accumulate acetate to the growth medium in a fed-batch cultivation when 
the specific growth rate exceeds 0.17 h-1 [97]. ADP1, on the other hand, does not produce acetate, 
even at elevated growth rates when cultivated on glucose (see Results and Discussion). A. baylyi 
strains, however, produce acetate as an intermediate of EtOH catabolism and this organic acid 
can accumulate in the growth medium when grown on EtOH [1], [145]. Acetate production from 
EtOH also occurs with ADP1 (see Results and Discussion). The lack of acetate production is a 
beneficial trait because acetate accumulation can harm the bioprocess in many ways. Acetate 
formation reduces recombinant protein yields with E. coli [41]. Acetate can also inhibit the growth 
of E. coli K12 at low (0.5 g/l) concentrations [126]. The growth-inhibitory effect of acetate varies 
widely between different bacterial strains [102]. The carbon sources and the medium composition 
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also affect the toxicity of acetate. For example, acetate is more toxic to E. coli in the presence of 
glucose than glycerol in a rich medium [102], but the opposite occurs in a minimal medium [126]. 
Overexpression of phosphoenolpyruvate carboxylase, ppc, has been shown to reduce acetate 
formation from glucose by E. coli [49]. Acetate formation from glucose by Bacillus subtilis has 
been reduced by knocking out the gene for pyruvate kinase, which also improved the yield of the 
biomass and reduced growth rate [60]. Similar results have been obtained with E. coli with both 
genes for pyruvate kinase knocked out, which had lowered the growth rate and reduced acetate 
production [146]. The elimination of acetate formation by knocking out genes involved in its syn-
thesis has been used to improve the production of pyruvate [22] and citramalate [140] by E. coli. 
Among these genes is poxB, the product of which funnels carbon away from product formation 
in these strains. Recently, acetate excretion by E. coli has been reduced by a synthetic biology 
application where the expression of pta, ackA and poxB were controlled by light at three different 
wavelengths [51]. E. coli produces acetate primarily through the Pta-AckA pathway [197]. The 
Pta-AckA pathway simultaneously produces and consumes acetate, while the direction of the 
carbon flow is determined by thermodynamic factors, i.e. the concentrations of reactants and 
products [47]. Thus, acetate excretion by E. coli K-12 MG1655 during growth on glucose is not 
due to repression of acetate catabolism, but due rather to the higher flux of the acetate production 
than the acetate consumption. 
2.5.2.4 Aromatic compound metabolism 
The aromatic compound 4-HB, which was used in the experiments for this thesis as a repre-
sentative of lignocellulosic hydrolysate’s aromatic inhibitors, is catabolized by ADP1 into suc-
cinyl-CoA and acetyl-CoA (Figure 2). The catabolism of 4-HB begins with its transport into the 
cell via PcaK [141]. It is then converted to protocatechuate and, after four reactions, into β-ke-
toadipate intermediate, which is then converted by two reactions into acetyl-CoA and succinyl-
CoA [53]. 
The catabolism of aromatic compounds in ADP1 is subject to complex control mechanisms [16], 
[27]. There are several carbon sources that repress the catabolism of aromatic compounds, two 
of the strongest of these being succinate and acetate [27]. This is unfortunate, as acetate is often 
found in lignocellulosic hydrolysates at high (10 g/l) concentrations [179]. In addition to repres-
sion by organic acids, some of the catabolizable aromatic compounds repress the catabolism of 
other, less desirable aromatic molecules [16]. The catabolite repression of aromatic compounds 
could be decreased by knocking out genes like crc [207], the products of which decrease these 
metabolic activities in ADP1. Glucose does not act as a catabolite repressor of aromatic com-
pound catabolism [27]. Gluconate represses the catabolism of some aromatic compounds only 
to a small degree, and acts as an inducer for one (catA) of the pathways [16]. Amplification of 
the genes responsible for benzoate catabolism in a mutant lacking the two benzoate-catabolism 
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inducer genes has been shown to allow benzoate catabolism [151]. The combined weak expres-
sion of the genes from multiple copies allowed enzyme activities high enough to support growth 
on benzoate [151]. 
2.5.2.5 Wax ester synthesis 
WEs are esters of fatty acids and fatty alcohols (Figure 4) and occur in nature as carbon storage 
material for plants like Jojoba (Simmondsia chinensis) [158], and microorganisms such as Eu-
glena gracilis [70] and A. baylyi [56]. Jojoba is a perennial shrub that stores WEs in its seeds and 
grows mainly in deserts, but can also be cultivated in other environments [158]. WE synthesis 
has also been engineered in Nicotiana benthamiana in order to allow it to occur in plants which 
can grow in a broader range of conditions [8]. The WEs of the Jojoba plant usually contain 40 to 
42 carbon atoms, and both the fatty acyl and fatty alcohol parts are mono-unsaturated [121]. E. 
gracilis synthesizes a carbohydrate paramylon as a means of carbon and energy storage under 
aerobic conditions, and when the growth cultivations are changed to anaerobic, converts the 
paramylon to WEs which also generate ATP [70]. The WEs of E. gracilis are mainly composed 
of saturated compounds containing 27 to 30 carbons [71]. A. baylyi produces WEs most effi-
ciently in the presence of an excess carbon source and the simultaneous starvation of other 
essential nutrients such as nitrogen [56]. The WEs of ADP1 consist mainly of C16:0, C16:1 and 
C18:1 fatty acids and fatty alcohols [162]. The WEs of BD4, the parental strain of ADP1, also 
contain mainly these fatty alcohols [19]. The placement of the double bonds and their configura-
tion are not known for the WEs of ADP1, but it has been shown that the WEs of A. calcoaceticus 
NCIB 8250, which also contain mostly fatty acids and fatty alcohols with a chain length of 16 or 
18 carbons, have the double bonds between carbons 9 and 10 and have a cis configuration 
(Figure 4) [56]. Fatty acyl and fatty alcohol compositions of WEs of other A. baylyi species do not 
differ dramatically from the composition of the WEs of ADP1 mentioned above [55], but the WEs 
of some psychrotrophic members of Acinetobacter appear to contain short (C3v – C5) alcohols 
[62]. WE synthesis has been engineered in microorganisms like E. coli [89], [175] and S. cere-
visiae [190], which do not naturally produce these compounds. 
 
FIGURE  4 An example of a WE structure. This kind of WE is produced by for example, A. calcoaceti-
cus NCIB 8250 [56]. 
WEs can be used in the cosmetics and pharmaceutical industries, as a lubricant, or as a raw 
material for biodiesel production, to name a few applications [121], [158]. Jojoba oil acts as a 
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moisturizer and can thus be used to improve skin care products [158]. Jojoba oil has anti-inflam-
matory properties and has long been used by the native peoples of America to treat inflammatory 
diseases [158]. Jojoba oil can also be used as an additive in diesel [6], [69] or transesterified with 
short-chain alcohols like methanol to produce biodiesel [20]. However, due to the high price of 
Jojoba oil, it is probably economically more feasible to use this lipid in other applications. The 
production of Jojoba oil has increased dramatically in recent years due to the increased demand 
for this lipid [158]. The applications where Jojoba oil is used keep increasing, which creates this 
increased demand [158]. It has been noted that there is a need for an inexpensive way to produce 
large quantities of WEs to meet the demands of various industries [87]. The WEs used in indus-
trial applications today are produced from Jojoba, but producing WEs from microorganisms has 
many advantages as they are easier to engineer genetically, and can be fed on different carbon 
sources, thus allowing better control of the composition of the resulting lipids [4]. 
While WEs already have several commercial applications, they could be further improved by 
means of metabolic engineering. For example, the properties of Jojoba plant WEs as biofuel 
could be further improved by lowering the viscosity [20]. The viscosity of WEs produced by ADP1 
could be lowered with WE synthases with different substrate specificities [173]. On the other 
hand, the composition of the WEs produced from ADP1 could be modified to more closely re-
semble those of the Jojoba plant by metabolic engineering, as has been done with S. cerevisiae 
engineered to produce WEs [190]. The structure of WEs produced by A. baylyi ADP1 could also 
be modified so that it contained branches, as has been done with E. coli [118], which improves 
properties of WEs as lubricants. It has been proposed that the commercialization of bioprocess 
products might be easier for specialised applications than it is for fuels, for example [65]. Thus, 
being able to tailor the structure of the WE might make the WE-producing bioprocesses using 
ADP1 more economically feasible. 
The microbial synthesis of lipids begins with the formation of malonyl-CoA from acetyl-CoA by 
carboxylation, a reaction that consumes one molecule of ATP [75]. Malonyl-CoA is then trans-
ferred to the acyl carrier protein, forming malonyl-ACP. The malonyl-ACP is condensed with ac-
etyl-CoA to produce acetoacetyl-CoA, which is converted into butyryl-CoA through two reduc-
tions and one dehydration reaction. Both of these reduction reactions consume two nicotinamide 
adenine dinucleotide phosphate (NADPH) molecules. Butyryl-CoA is condensed with malonyl-
ACP and the cycle is repeated until a full-length acyl-ACP has been formed. Thus, elongation of 
the growing fatty acid chain by two carbons consumes one molecule of ATP and two molecules 
of NADPH. In WE synthesis by ADP1, the fatty acyl-CoA is reduced to fatty aldehyde in an 
NADPH-consuming reaction by Acr1, a fatty acyl-CoA reductase encoded by acr1 [152]. Acr1 
can catalyze the reduction of fatty acyl-CoAs with 14 to 22 carbons (but not with 12 or 24 carbons) 
and most favourably reduces hexadecanoyl-CoA [152]. The enzymatic step for the conversion 
of fatty aldehydes to fatty alcohols has not been elucidated. In the last step in the synthesis of 
WEs, a fatty acyl-CoA and a fatty alcohol are condensed to a WE molecule, liberating a CoA-SH 
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molecule [87]. This reaction is catalyzed by the WE synthase/acyl-CoA:diacylglycerol acyltranfer-
ase (WS/DGAT) [87], which is mainly located on the inner surface of the cell membrane and at 
the surface of the WE bodies, although it occurs to lesser degree in cytosol [177], [199]. 
WS/DGAT catalyzes, as its name suggests, and also synthesises triacylglycerols, but this activity 
is only about a tenth of the WE synthase activity [87]. WS/DGAT has a low substrate specificity 
[177], which has been utilized in engineering the production of fatty acid ethyl esters (FAEE) in 
S. cerevisiae [86], [173] and E. coli [88]. This E. coli strain has been used in a 20-liter fed-batch 
cultivation where a biomass of 61 g/l and a FAEE content of 18.5 % were obtained, by first 
cultivating a high cell density with glycerol and then producing the FAEEs from glucose and oleic 
acid [44]. The limitation of having to feed the microorganism with fatty acids has been recognised 
by Elbahloul & Steinbüchel, and they suggested [44] that this process could be carried out in 
bacteria naturally producing large quantities of storage lipids, such as Acinetobacter sp. strain 
211, which produces up to 25 % of DCW lipids when cultivated on olive oil [5]. Other ester bond-
forming enzymes have been characterized and used in the production of molecules such as ethyl 
acetate, isobutyl alcohol, and tetradecyl acetate in E. coli [117].  It has been suggested that ADP1 
might be a suitable host organism for biodiesel production [45], but so far biodiesel production 
has not been engineered in ADP1. 
WS/DGAT appears to be present in the ADP1 cell at a low copy number [199]. It has been pro-
posed that the synthesis occurs at the inner cell membrane, where the WS/DGAT enzymes are 
docked prior to the beginning of the WE synthesis. These enzymes catalyze the formation of 
small lipid droplets, to which phospholipids attach, forming lipid pre-bodies. The lipid pre-bodies 
dissociate themselves from the membrane-bound enzymes and the small lipid droplets inside 
them aggregate, which results in the formation of mature lipid bodies. The mature lipid bodies of 
WEs are surrounded by a monolayer of phospholipids and are spherical in ADP1 [199], while in 
other A. baylyi strains WEs can be found with differently-shaped lipid bodies [200]. Acinetobacter 
sp. HO1-N has been shown to excrete WEs, free fatty acids, and mono-, di- and tri-glycerides 
(but not significantly free fatty alcohols) to the growth medium when cultivated on hexadecane 
[108]. The growth medium did not contain a significant amount of these molecules when the cells 
were cultivated in a rich medium [108]. The growth medium also did not contain phospholipids 
when cultivated in a rich medium or on hexadecane, which indicates that the cells did not liberate 
the lipids by lysis [108]. 
The accumulation and utilization of WEs by ADP1 is shown schematically in Figure 5. The time 
needed to reach time-points A, B and C depends on the carbon source used, and in the experi-
ments for this thesis it took several days to reach time-point C. Prior to time-point A, the cells 
grow and synthesize WEs. At time-point A, the growth becomes limited by a nutrient other than 
the carbon source, for example nitrogen, and this is when WEs are accumulated most efficiently 
[56]. WEs continue to accumulate in the cells until time-point B, when the cells have depleted the 
growth medium of the carbon source. At this point, the cells start to consume WEs as a source 
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of carbon and energy. When the cells have consumed all of their WE reserves (time-point C) the 
number of cells starts to decrease. Therefore, the optimal point for collecting the cells in a WE-
producing bioprocess is time-point B. 
 
FIGURE  5  A schematic presentation of WE accumulation by ADP1. The number of cells is shown with 
a continuous line, the amount of WEs with a dashed line, and the amount of the carbon 
source with a dotted line. Adapted from [56]. 
The WE contents of bacteria are often only a fraction of what Jojoba seeds or E. gracilis contain. 
The highest WE content with bacteria (17 %) was obtained by feeding an A. baylyi strain with 
alkanes [72]. These carbon sources differ greatly from the ones used in this thesis since their 
incorporation into WEs requires only few metabolic steps [73]. Because of this, this value (17 %) 
cannot be compared with the WE yields obtained by cultivating the bacteria on lignocellulose-
derived carbon sources. WE production has been enabled in Rhodococcus opacus PD630 by 
expressing a heterologous fatty acyl-CoA reductase [101] and in Rhodococcus jostii RHA1 by 
overexpressing a fatty acyl-CoA reductase naturally present in the organism [156]. Neither the 
WE percentage of DCW or the WE titer were reported for R. opacus PD630, but WEs constituted 
46 % of the neutral lipids produced and the strain accumulated over 40 % of DCW of neutral 
lipids in a separate cultivation [101]. This suggests that this strain has the potential to accumulate 
large quantities of WEs but its suitability as a bioprocess host organism cannot be evaluated 
before the WE production by the strain has been properly characterized. R. jostii RHA1 accumu-
lated WEs up to 13 % of DCW, but the cultivation took 72 hours to complete and the authors did 
not report the amount of biomass produced [156]. Thus, WE productivity and its titer might remain 
low with this organism unless its growth rate and final biomass obtained can be improved. 
2.5.3 Biotechnological applications 
Acinetobacter strains have been considered suitable for several biotechnological applications, 
including bioremediation, the production of biochemical, and as biosensors [2], although most of 
26 
 
this research involved basic microbiological science [79]. Much of the research work carried out 
with ADP1 has focused on genetics and metabolism, but more recently on biotechnological ap-
plications too [45]. For example, Lehtinen et al. have used ADP1 to produce WEs indirectly from 
electricity and CO2 [105]. In this application Sporomusa ovata first converts CO2 and electricity 
to organic acids, and then the ADP1 converts the organic acids into WEs [105]. Santala et al. 
have used a gntT KO mutant of ADP1 that is unable to transport gluconate into the cells. They 
used this in a co-cultivation to consume the acetate produced by E. coli as an overflow metabolite 
of glucose catabolism [163]. The production of triacylglycerols with metabolically-engineered 
ADP1 has been studied by Santala et al. [161], while Lehtinen et al. have engineered ADP1 for 
the production of alkanes [106]. Elbahloul et al. have studied cyanophycin production with ADP1 
by optimizing growth conditions [42], and by means of metabolic engineering [43]. A. calcoaceti-
cus RAG-1 has been studied with respect to its ability to produce emulsans [172] and the struc-
ture of the produced emulsan has also been engineered [78]. Even though ADP1 also produces 
EPSs that have emulsifying properties [91], the EPS produced by ADP1 has not been studied 
extensively or subjected to engineering. The first step in the glucose catabolism of A. baylyi has 
been harnessed in the production of D-xylulose [147]. In this application, D-xylulose is formed 
enzymatically from D-xylose by xylose isomerase. Then A. baylyi cells are used to convert the 
residual D-xylose to D-xylonic acid, which is then removed with methanol precipitation and ion 
exchange. ADP1 has also been used as a host for biosensor applications where the synthesis 
of WEs [160] or the synthesis or degradation of alkanes [106] have been monitored in real time. 
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The main goal of this work was to improve the growth and WE production by ADP1 on the main 
components of lignocellulosic biomass, i.e. sugars, aliphatic acids and aromatic compounds. As 
discussed above, ADP1 can use glucose, aliphatic acids like acetate, and certain aromatic com-
pounds like 4-HB as carbon sources. Since ADP1 grows relatively poorly on glucose (low growth 
rate and biomass yield), and glucose is the most abundant component of lignocellulosic hydrol-
ysates, much research has concentrated on glucose utilization. The unique characteristics of the 
metabolism of ADP1, such as the lack of certain glycolytic enzymes and production of EPSs, 
made it possible to test whether modification of its main metabolic pathways would improve the 
growth characteristics or the WE production. The objectives of this thesis are summarized below 
(the publications where these aspects were studied are shown in parentheses): 
• Improvement of growth rate (Publications I & IV) 
• Improvement of biomass yield (Publications III & IV) 
• Improvement of WE yield, titer and purity (Publications III & IV) 
• Improvement of tolerance towards a lignocellulosic inhibitor acetate (Publication IV) 
• Production of a lignocellulosic hydrolysate biodetoxification strain (Publication II) 
The selective advantage of the lack of pyruvate kinase in ADP1 is not known. However, the 
unencapsulated mutants of BD4 lyse when cultivated on glucose, which has been considered to 
be due to the lack of pyruvate kinase activity [82]. Thus, it could be hypothesized that the ex-
pression of a gene for this enzyme might affect the growth characteristics of the mini-encapsu-
lated WT ADP1. 
The EPS capsule is the major by-product in WE production with ADP1. Although unencapsulated 
mutants of BD4 have been produced before, the effects of these mutations on growth, or on 
macro-molecular composition, have not been characterized. It is hypothesized that by knocking 
3 Research Objectives and Questions 
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out the gene for the first step in the synthesis of the most abundant component of the EPS of 
ADP1, the growth and WE production might be affected on three components of lignocellulosic 
hydrolysates: glucose, acetate and 4-HB. The established hypothesis that the lysis of the unen-
capsulated cells grown on glucose is due to the lack of pyruvate kinase activity was also tested. 
Lignocellulosic hydrolysates often contain large amounts of acetate, thus making it a major car-
bon source in WE-producing bioprocesses that use ADP1 as a host organism and lignocellulosic 
hydrolysates as a raw material. While ADP1 does not excrete acetate when cultivated on glucose, 
the strain has a gene for the production of this organic acid from pyruvate. The formation of 
acetyl-CoA from acetate requires ATP, and thus the presence of this enzymatic activity might 
waste energy, and thus affect the growth and WE production in growth media containing glucose 
and/or acetate. 
The presence of multiple pathways for sugar catabolism has been shown to be a problem in 
engineering E. coli for biodetoxification [100]. Furthermore, S. cerevisiae engineered for selective 
acetate removal also consumes the sugars present in the cultivation medium to some degree 
[169]. This problem has also been encountered with bacterial strains used in biodetoxification 
which have not been subjected to metabolic engineering [58]. ADP1 has a single enzymatic step 
for oxidation of all lignocellulosic sugars: the first step in its glucose catabolism, catalyzed by 
GDH. It was hypothesized that ADP1 could outperform the above-mentioned strains if the gene 
for this enzymatic step was knocked out. 
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4.1 Metabolic engineering 
All metabolically engineered strains (Table 2) were produced from A. baylyi ADP1 (DSM 24193) 
or strains derived from it by KO mutations (Figure 6). Construction of the plasmids and gene KO 
cassettes was performed according to well-established methods [157]. The KO cassettes used 
to produce KO mutations of gcd, rmlA and poxB were constructed from the KO cassettes of 
Santala et al. [161] by changing the flanking sites and the antibiotic resistance marker when 
necessary. The plasmid backbone used was pBAV1C [162], which is a chloramphenicol (Cm) 
resistant version of the pBAV1K plasmid [18]. The gene for pyruvate kinase, pykF, was cloned 
from E. coli K12 MG1655 and was expressed under control of the arabinose promoter, which 
has been shown to work well in ADP1 [125]. The primers used to clone pykF contained standard 
BioBrick restriction sites [95]. Metabolic modelling of the effects of the pykF expression on the 
metabolism of ADP1 was done with metabolic flux balance analysis [50]. The control plasmid, 
pBAV1C, was produced by removing the promoter from pBAV1C-pBAD with XbaI and SpeI and 
ligating the plasmid backbone with itself. All the transformations of ADP1 were carried out as 
explained by Metzgar et al. [119]. Successful construction of the metabolically engineered strains 
was verified by amplifying the modified regions with PCR and analyzing the sizes of the PCR 
products with agarose gel electrophoresis. 
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TABLE 2  The metabolically engineered Acinetobacter baylyi strains used in the experiments. 
Strain designation used 
in this thesisa 
KO mutation(s)/antibiotic 
marker(s) Plasmid/antibiotic marker Publication(s) 
ADP1 - - I, II, III 
ADP1_ctrl - pBAV1C/Cm I 
ADP1_pykF - pBAV1C-pBAD-pykF/Cm I, III 
ADP1Δgcd gcd (ACIAD2983)/Cm - II 
ADP1ΔrmlA rmlA (ACIAD0079)/Cm - III 
ADP1ΔrmlA_pykF rmlA (ACIAD0079)/Km pBAV1C-pBAD-pykF/Cm III, IV 
ADP1ΔrmlAΔpoxB_pykF rmlA (ACIAD0079)/Km, poxB (ACIAD3381)/Spec pBAV1C-pBAD-pykF/Cm IV 
aDifferent designations may have been used in the Publications I-IV 
 
FIGURE  6  Lineage of the Acinetobacter baylyi strains used in the experiments. The strain names are 
shown inside the representations of the cells and the presence of the EPS capsule is 
shown in grey. 
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4.2 Cultivation of the cells 
The cultivations were carried out at 30 °C at 300 rpm in 250 ml Erlenmeyer flasks, which were 
closed with a loose aluminium foil and contained 50 ml of medium. Co-cultivations with Clostrid-
ium butyricum were carried out in sealed 25 ml glass tubes containing 10 ml of the medium. 
Cultivation of the bacteria for transformations was carried out in a slightly modified version of the 
LB medium [14] which had the following composition: 10 g/l tryptone, 5 g/l yeast extract, 5 g/l 
NaCl. The platings of the bacteria were carried out on a solid medium, which had a similar com-
position to the LB medium described above but also contained 15 g/l of agar. The minimal me-
dium used in the experiments had the following composition: 5.1 g/l K2HPO4, 3.4 g/l KH2PO4, 1.0 
g/l NH4Cl, 0.3 g/l MgSO4, 22.2 mg/l CaCl2, 4.2 mg/l FeCl3 (and 2.0 g/l CAA when appropriate). 
The co-cultivations with C. butyricum were carried out in the medium used by Seppälä et al. [171] 
but with slight modifications: 1.5 g/l K2HPO4, 2.0 g/l (NH4)2SO4, 0.2 g/l MgSO4*7H2O, 0.015 g/l 
CaCl2*2H2O, 0.005 g/l FeSO4*7H2O, 0.3 g/l yeast extract, 2 ml/l of trace element solution (1.0 
ml/l 25 % HCl, 70 mg/l ZnCl2, 100 mg/l MnCl2*4H2O, 60 mg/l H3BO3, 200 mg/l CoCl2*6H2O, 20 
mg/l CuCl2*2H2O, 20 mg/l NiCl2*6H2O and 40 mg/l Na2MoO4*2H2O). The antibiotics used in the 
transformations were added to the growth media from stock solutions to achieve concentrations 
of 25 – 50 mg/l (Cm), 50 mg/l (Km), or 100 mg/l (Spec). In the cultivation experiments, 25 – 50 
mg/l of Cm was used. For experiments where it was intended to cultivate the bacteria using a 
substrate as a sole carbon source, the stock solution was not used and the Cm was dissolved 
directly into the growth medium. This was done in order to prevent the EtOH from the Cm stock 
solution (prepared in 70 % EtOH) from interfering with the experiment. The carbon sources used 
in the publications of this thesis are shown in Table 3. The calculations for the optimization of the 
substrate and pykF inducer concentrations in Publication I were done with MATLAB [112]. 
TABLE 3 Carbon sources used in the experiments. 
Carbon source Publication 
Glucose I, II, III, IV 
Gluconate I 
Arabinosea II 
Xylose II 
Levulinate II 
Acetate II, III, IV 
Formate II 
4-HB II, III 
EtOH III, IV 
Rice straw hydrolysate II 
aThe experiments where arabinose was used as an inducer of pykF expression are not listed here. 
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4.3 Measurement of growth and metabolites 
The measurements carried out in the experiments are summarized in Table 4. The growth of the 
bacterial strains was measured spectrophotometrically (growth rate) or gravimetrically (DCW). Con-
centrations of the small metabolites were determined spectrophotometrically or by chromatographic 
methods, and the pH was measured with a pocket pH meter. In the preparation of the rice straw 
hydrolysate used in Publication II, a dinitrosalisylic acid assay was used instead of HPLC. The lipids 
were solvents extracted from the cells and the total lipid content was measured gravimetrically. The 
number of WEs was determined either semi-quantitatively (TLC) or quantitatively (NMR) from the 
extracted lipids. In Publication I, the expression level of pykF in ADP1 was determined with an en-
zymatic assay. In Publication III, the aggregation of the rmlA KO strains was shown to occur by 
inspecting the cells with a light microscope. 
TABLE 4 The methods used to measure growth and metabolite concentrations in the experi-
ments. 
Measured parameter Method Publication 
OD600 Spectrophotometer (600 nm) I, II, III, IV 
DCW (or weight of the NMR sample) Gravimetric analysis (after lyophilization) III, IV 
c4-HB Spectrophotometer (280 nm) as in Dal et al. [27] II, III 
cH2 GC as in Mangayil et al. [109] II 
cwax esters (quantitative) NMR (after solvent extraction) III, IV 
cwax esters (semiquantitative) TLC (after solvent extraction) I, III, IV 
cglucose HPLC I, II, III, IV 
cglucose Dinitrosalicylic adic assay [120] II 
cother metabolites HPLC I, II, III, IV 
Total lipid content Gravimetric analysis (after solvent extraction) III, IV 
Pyruvate kinase activity Enzymatic assay as in Netzer et al. [128] I 
pH pH meter III, IV 
Cellular aggregation Light microscopy III 
 
33 
 
5.1 Improvements in growth 
5.1.1 Growth rate 
The specific growth rates for A. baylyi strains on various carbon sources are shown in Table 5. 
The highest growth rates were obtained with malate and oxaloacetate, which are TCA cycle 
intermediates. Pyruvate and acetate produce intermediary growth rates when used as carbon 
sources, while only low growth rates can be obtained when using glucose as the carbon source. 
4-HB, which is catabolized to succinyl-CoA and acetyl-CoA, also supports the intermediary 
growth rate. It has been hypothesized that the lack of pyruvate kinase activity in BD4, the parental 
strain of ADP1, causes some of the carbon from the glucose catabolism to get stuck in the gly-
colysis of the unencapsulated mutants, causing cells to lyse [82]. One way to reduce the con-
centrations of glycolytic intermediates in ADP1 is to improve the flux from glycolysis to the TCA 
cycle by expressing pykF. The expression of pykF would also reduce the number of enzymatic 
steps needed to produce pyruvate from PEP. Metabolic pathways usually involve a minimum 
number of enzymatic steps to produce one essential metabolite from another [132], so it could 
be expected that this simplification of metabolism might improve the growth of ADP1. The use of 
pyruvate kinase also yields one molecule of ATP per conversion of PEP to pyruvate, while py-
ruvate formation from PEP via oxaloacetate and malate intermediates, the pathway used by WT 
ADP1, yields none. It was considered worthwhile to test whether the growth rate of ADP1 on 
glucose could be improved by expressing pykF, a gene for pyruvate kinase from E. coli. 
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TABLE 5  Growth rates in the exponential growth phase of A. baylyi strains on different carbon 
sources. 
Strain Carbon source Concentration (mM) μ (h-1) Reference 
ADP1 Glucose 28 0.15 [91] 
BD4 Glucose 28 0.26 [91] 
ADP1 Glucose 10 0.25 [188] 
ADP1 Glucose 10 0.19 Publication III 
ADP1_ctrl Glucose 82 0.18 Publication I 
ADP1_pykF Glucose 82 0.42 Publication I 
ADP1_pykF Glucose 10 0.30 Publication III 
ADP1ΔrmlA_pykF Glucose 10 0.28 Publication III 
ADP1ΔrmlA_pykF Glucose 22 0.36 Publication IV 
ADP1ΔrmlAΔpoxB_pykF Glucose 21 0.25 Publication IV 
ADP1_ctrl Gluconate 76 0.12 Publication I 
ADP1_pykF Gluconate 75 0.44 Publication I 
ADP1 Malate 38 1.09 [34] 
ADP1 Pyruvate 57 0.67 [34] 
ADP1 Oxaloacetate 38 1.04 [34] 
ADP1 Acetate 10 0.69 Publication III 
ADP1ΔrmlA Acetate 10 0.52 Publication III 
ADP1 4-HB 10 0.55 Publication III 
ADP1ΔrmlA 4-HB 10 0.56 Publication III 
It was shown that there is a correlation between added inducer concentration, pyruvate kinase 
activity, and the specific growth rate of ADP1_pykF on gluconate (Publication I). With ADP1_ctrl 
there was no increase in pyruvate kinase activity with increasing inducer concentration, but its 
specific growth rate increased slightly. This is most likely due to the fact that the cells were culti-
vated on gluconate and the GDH oxidation of sugars (here the inducer, arabinose) allows the 
cells to grow faster [187]. If glucose had been used as a carbon source, this effect would probably 
have been smaller, or even non-existent, because glucose is more preferred substrate than arab-
inose for the GDH of A. baylyi LMD79.41 [33] and ADP1 (see Figure 1a in Publication II). Be-
cause the growth rate was found to be dependent on the expression level of pykF, it was decided 
to attempt to optimize the growth rate by varying the glucose and arabinose concentrations. This 
was done in order to find out the maximum effect of pykF expression so that its other possible 
effects on the metabolism of the bacterium could be determined in subsequent experiments. 
Two batch cultivations were carried out at optimized substrate and inducer concentrations, using 
gluconate or glucose as carbon sources. The metabolism of the former starts at a later point in 
the ED glycolysis of ADP1 (Figure 2). The gluconate allows the cell to start growing earlier than 
it would when cultivated on glucose since the oxidation of glucose to gluconate causes the cells 
to endure a longer lag phase [188]. Glucose, on the other hand, yields more energy through 
reactions by GDH and lactonase, and thus gluconate has a lower energy content than glucose. 
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The presence of glucose also prevents oxidation of the inducer, arabinose, to arabinolactone, 
which allows the expression of pykF to be maintained at an appropriate level. When cultivated 
on gluconate, it took approximately twice as long for ADP1_ctrl to grow to the stationary phase 
than ADP1_pykF, while both strains had a lag phase of similar length. Furthermore, when culti-
vated on glucose the cells also experienced lag phases of approximately the same length, but 
ADP1_pykF grew faster. The difference between the growth rates of the strains was more pro-
nounced on glucose than when gluconate was used as a carbon source. This could be due to 
the fact that more energy can be obtained from glucose than gluconate, and the use of gluconate 
allows arabinose oxidation by GDH, which decreases pykF expression and thereby the growth 
rate. The oxidation of arabinose when ADP1_pykF is grown on gluconate resulted in a more 
linear growth than when glucose was used as a carbon source (Publication I). The growth of 
ADP1_pykF on glucose ceased to be exponential after approximately half of the carbon source 
had been depleted. There could be several reasons for this. One explanation for this behaviour 
is that some other medium component was depleted at this point, for example nitrogen, after 
which the cells merely accumulated WEs. On the other hand, since conversion of glucose to 
gluconate by GDH and gluconolactonase decreases the pH of the medium, it might be that the 
pH of the medium started to decrease at this point, if the buffering capacity of the used buffer ran 
out. 
The rmlA KO eliminated EPS capsule formation and decreased the growth rate on acetate as a 
sole carbon source, but did not affect the growth rate when 4-HB was used as a sole carbon 
source (Publication III). The rmlA KO diminished the growth rate of ADP1 on glucose, as could 
be expected. However, the expression of pykF restored the growth rate of ADP1ΔrmlA to a sim-
ilar level to that of ADP1_pykF. Thus, the rmlA KO did not affect the growth rate of ADP1_pykF 
on glucose. When poxB was knocked out from ADP1ΔrmlA_pykF, the growth rate on glucose 
decreased (Publication IV). The decrease in growth rate (and also biomass yield) on glucose has 
also been shown to occur with the poxB KO strain of E. coli [3]. The growth rate of 
ADP1ΔrmlAΔpoxB_pykF in the exponential growth phase was also lower than that of 
ADP1ΔrmlA_pykF when the medium contained glucose, CAA and EtOH, but was unaffected in 
a medium containing either acetate alone, or glucose, CAA and acetate (Publication IV). When 
the cells grew linearly, the growth rate was similar for both strains on glucose alone but when 
cultivated on glucose, CAA and acetate, the ADP1ΔrmlAΔpoxB_pykF grew significantly faster 
than the ADP1ΔrmlA_pykF. This indicates that whether poxB KO increases or decreases the 
growth rate of ADP1ΔrmlA_pykF depends on the medium composition. However, since lignocel-
lulosic hydrolysates often contain large amounts of both glucose and acetate, poxB KO might be 
beneficial with respect to growth rate in bioprocesses where WEs are produced with 
ADP1ΔrmlA_pykF from lignocellulosic hydrolysates. 
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5.1.2 Biomass yield and final biomass of the cultivation 
The biomass yield (grams of biomass per gram of substrate) from glucose with ADP1_pykF (0.37 
± 0.04 gCells /gGlucose) (Publication III) is significantly lower than what is usually obtained with E. 
coli (0.5 gCells /gGlucose) [174], although it is in the same range as what has been obtained with the 
E. coli strain HB101 (0.35 gCells /gGlucose) [170]. The value obtained with ADP1_pykF might be 
slightly lowered by the presence of pBAV1C-pBAD-pykF in the cells, since plasmid maintenance 
reduces biomass yield [170]. This effect is larger with high-copy-number plasmids [170]. Indeed, 
pBAV1K-T5-luxABCDE, the plasmid containing the backbone from which pBAV1C-pBAD-pykF 
has been derived, has a copy number of ~60 in ADP1 [18]. The plasmid RSF1050, which also 
has a copy number of 60 and is approximately same size (7.4 kb [36]) as pBAV1K-T5-luxABCDE 
(8.6 kb) [18]), decreases the biomass yield of E. coli HB101 from 0.35 gCells /gGlucose (μ = 0.42 h-
1) to 0.30 gCells /gGlucose (μ = 0.36 h-1) in a minimal medium on glucose [170]. Thus, it could be 
expected that the presence of pBAV1C-pBAD-pykF (5 - 6 kb (Publication IV)) might, at least 
partly, explain the relatively low biomass yield from glucose of ADP1_pykF. The expression of 
pykF, which increased the growth rate, did not affect biomass formation based on OD600 and 
glucose consumption values (Publication I). 
Since EPS constitutes a large portion of the biomass of ADP1 (see Exopolysaccharide metabo-
lism), an rmlA KO mutant was constructed and its growth on glucose, acetate and 4-HB was 
characterized to see if biomass yield could be improved (Publication III). The strain grew poorly 
on glucose, but the expression of pykF allowed proper growth. When ADP1ΔrmlA was cultivated 
on glucose, the absorbance of the growth medium at a wavelength of 280 nm increased signifi-
cantly (1.55 ± 0.02). This was assumed to be caused by lysis of the cells. In the WT ADP1 
cultivation, absorbance at 280 nm was also slightly increased (0.05 ± 0.01), but this could be 
expected since it has been shown that ADP1 undergoes lysis to a small degree during exponen-
tial growth [136]. However, although ADP1ΔrmlA_pykF had an increased WE yield (see below), 
the biomass yield from glucose was lowered to 0.23 ± 0.07 gCells /gGlucose (Publication III). On 
acetate, the biomass yield of 0.52 ± 0.09 gCells /gAcetate obtained with WT ADP1 in these experi-
ments is significantly higher than what has been obtained by O´Beirne & Hamer with E. coli 
W3310, who reported a biomass yield of 0.25 gCells /gAcetate [133]. The rmlA KO did not significantly 
affect the biomass yield from acetate (0.58 ± 0.12 gCells /gAcetate). The biomass yield from 4-HB 
was also quite high for both ADP1 (0.52 ± 0.02 gCells /g4-HB) and ADP1ΔrmlA (0.49 ± 0.06 gCells 
/g4-HB). Thus it seems that the effects of the rmlA KO mutation are specific to cultivations carried 
out on glucose, and cannot be applied to cultivations on carbon sources such as acetate and 4-
HB. This could be due to the peculiarities of glucose catabolism by ADP1 (see Figure 2). Never-
theless, the high biomass yields of ADP1 from the common inhibitors found in lignocellulosic 
hydrolysates, acetate and 4-HB, indicate that this strain might be suitable for efficient WE pro-
duction from these compounds. 
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ADP1 cannot grow on sugars other than glucose [181], which limits the biomass obtained when 
cultivated on lignocellulosic hydrolysates. Since the GDH of ADP1 also oxidizes pentoses, the 
catabolic pathways for pentose utilization would have to be oxidative. An oxidative xylose deg-
radation pathway of Caulobacter crescentus [176] has been successfully used in enabling the 
oxidative catabolism of xylose in Pseudomonas putida S12, which also possesses a gene for 
GDH [116]. P. putida S12 has also been engineered to catabolize xylose and arabinose via the 
phosphorylative pathway [115]. However, efficient pentose catabolism required inactivation of 
GDH, which did not affect glucose consumption of P. putida S12 [115]. ADP1 has only ED gly-
colysis and the inactivation GDH eliminates glucose catabolism (Publication II), so this strategy 
cannot be used with ADP1. 
The highest final biomass values obtained were 9.7 ± 1.4 g/l for ADP1_pykF (Publication III), 5.0 
± 0.1 g/l for ADP1ΔrmlA_pykF (Publication IV) and 5.2 ± 0.1 g/l for ADP1ΔrmlAΔpoxB_pykF 
(Publication IV). It should be noted, however, that these values were determined from samples 
that were not washed prior to lyophilization. The samples were not washed in order to ensure 
that no cells, and thus WEs, are lost during this phase, and also because the WE content of the 
cells might have changed during this time-consuming step. Thus, these samples contained extra 
mass from medium components that are not removed during lyophilization. Because of this, they 
do not represent the DCW of the cultivation, but rather the masses of the NMR samples. Also, 
the biomass value of ADP1_pykF probably contains more of these impurities since it does not 
form so dense pellet as the EPS capsule negative rmlA KO strains, and thus less medium is 
removed from the sample by removal of the supernatant after centrifugation. 
5.1.3 Biomass composition and aggregation of the cells 
The rmlA KO improved the purity of the produced WEs (see below) and made it easier to collect 
the cells by centrifugation, an effect caused by aggregation of the cells in the absence of the EPS 
capsule [81]. The lack of EPS production can be also considered an advantage because the 
excretion of EPS in the growth medium increases its viscosity, which in turn makes it more diffi-
cult to maintain good mixing and oxygenation of the growth medium [114]. However, it should be 
noted that it was not shown in the research article that the rmlA KO completely eliminates the 
synthesis of EPS, and so it cannot be ruled out that the ADP1ΔrmlA_pykF might produce smaller 
fragments of EPS in the growth medium. Rhamnose is part of the backbone of the EPS molecule 
produced by ADP1 (see Figure 4). Thus, it could be assumed that if the rmlA KO strain still 
produces some extracellular carbohydrates or EPS, they are either compounds of glucuronic 
acid, mannose and free glucose, or they are larger molecules with structures that do not contain 
rhamnose at all and are unable to form the EPS capsule around ADP1 cells. However, unidenti-
fied compounds were not observed in the HPLC analyses, indicating that at least free glucose or 
mannose were not produced. It should be also noted that ADP1 produces mannitol as a compat-
ible solute during salt stress and produces mannitol-1P from fructose-6 (and probably mannitol 
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from mannitol-1P) [159]. Thus, ADP1ΔrmlA might have altered salt stress tolerance due to the 
increased concentration of fructose-6P, the starting metabolite for mannitol synthesis. 
It has been shown that Acinetobacter sp. strain GJ12 grows as bacilli in a rich medium but as 
cocci in a poor medium [74]. It was suggested that this might be due to changes in the growth 
rate; under conditions allowing a slow growth rate, the cells would grow as small cocci, while 
under conditions allowing fast growth rate, they would grow as bacilli. The same kind of behaviour 
was observed with ADP1 (Figure S4 in Publication III). When grown on acetate or 4-HB, which 
allow faster growth rates, the cells were clearly larger and had a bacillar shape, but when grown 
on glucose, on which ADP1 grows slowly, there were also small cells with a coccal shape. The 
coccal shape of BD4 cultivated on glucose has been also observed by Taylor & Juni [181]. The 
phenomenon of cells being larger at high growth rates was first observed with Salmonella typhi-
murium in 1958 [166]. 
Although A. baylyi strains are usually considered to be non-pathogenic, they have been shown 
to be able to infect immune-compromised patients [24], and the EPSs produced by A. baylyi 
strains can harm the host macrophages and increase the pathogenicity of pathogenic bacteria 
[134]. In E. coli, adhesin Ag43 causes cells to aggregate and form biofilms [168], and biofilm 
formation is often the reason for persistent infections [26]. In E. coli ,a capsule prevents adhesin-
mediated aggregation and biofilm formation [168]. Because of these characteristics, a non-floc-
culating, EPS-negative A. baylyi strain [82] might be the safest alternative for bioprocesses. 
5.2 Improvements in the wax ester production 
In order to be economically feasible, the bioprocess producing WEs should have high productivity, 
yield, titer and WE content of the biomass. For example, some cultivation conditions may result 
in a high WE content of the cells, but this might only have been achieved after an unacceptably 
long cultivation time. On the other hand, if high WE content were obtained when the cells could 
not be cultivated to high cell density, the WE titer would remain low. 
5.2.1 Wax ester yield and productivity 
The rmlA KO improved the WE yield on glucose as the carbon source, but not when acetate or 
4-HB were used. It has been shown with the parental strain of ADP1 that the cells form approxi-
mately twice as large an EPS capsule on glucose than they do on acetate [181] and that the cells 
synthesize the EPS capsule much more rapidly and efficiently from glucose than from acetate 
[81]. Thus, it might be that the effects of the rmlA KO mutation on the WE synthesis of ADP1 are 
minimal on acetate since less carbon is directed to EPS synthesis. 
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The productivity in WE-producing bioprocesses can be increased (if WE-content of the cells does 
not change) by increasing the growth rate of the host organism. It was shown with TLC that the 
improved growth rate by pykF expression did not decrease WE accumulation by ADP1 (Publica-
tion I), thus increasing WE productivity. When the growth rate of A. baylyi is limited by nitrogen, 
the WE production increases with decreasing growth rate [56]. However, under carbon limitation, 
the growth rate slightly increases in WE production [56]. It is likely that the situation occurring 
when pykF is expressed in ADP1 is comparable to the latter case. As the rmlA KO did not affect 
the WE yield on acetate, but did lower the growth rate, it can be said that WE productivity was 
lowered by this modification (Publication III). This also applies to the poxB KO in 
ADP1ΔrmlAΔpoxB_pykF, which had unaltered WE production but a reduced growth rate on glu-
cose as a sole carbon source (Publication IV). The WE productivity of ADP1ΔrmlA on 4-HB was 
unaffected, since neither the WE yield or growth rate were changed (Publication III). On glucose 
as a carbon source, since the WE yield was improved and the growth rate unaffected, the rmlA 
KO could be said to have increased WE productivity by ADP1_pykF. However, since the rmlA 
KO increased the length of the lag phase on glucose, acetate and 4-HB, the amount of WEs 
produced per cultivation time cannot be accurately estimated solely from the growth rate and WE 
yield values. 
5.2.2 Wax ester titer 
The only WE titer that has been reported with a WT ADP1 is approximately 0.16 g/l (Table 6), 
which was obtained in a 48-hour cultivation [162]. By expressing pykF, a similar titer could be 
obtained in 26 hours in a medium containing glucose, CAA and EtOH and the rmlA KO further 
improved the WE titer in a similar cultivation (Publication III). When ADP1ΔrmlA_pykF was culti-
vated in a medium that contained glucose, CAA and acetate, a 24-hour cultivation resulted in 
doubling of the WE titer (Publication IV). Furthermore, under these conditions, 
ADP1ΔrmlAΔpoxB_pykF, which was able to utilize acetate more efficiently, produced a WE titer 
that is approximately three times higher than that of ADP1 or ADP1_pykF. Thus, if compared to 
the WT ADP1, the two KO mutations and expression of pykF tripled the WE titer while halving 
the cultivation time. A WE titer that is 1.8 times higher than the one obtained with 
ADP1ΔrmlAΔpoxB_pykF has been obtained with E. coli engineered for the production of multi-
methyl-branched long-chain esters (MBE) [118]. This value was, however, obtained in a high 
cell-density, fed-batch cultivation, where an OD600 of approximately 210 was achieved, and pro-
pionate, n-octanol and oleic acid were supplied to the growth medium [118]. E. gracilis, on the 
other hand, can produce a WE titer of 2.1 g/l when cultivated on glucose to a DCW of 4.2 g/l [71]. 
Thus, although E. coli can be routinely cultivated to high cell densities, it only seems to accumu-
late WEs to very small amount, making it difficult to increase the titers. The WE titer of ADP1 
strains could be increased significantly if high cell density cultivation methods were developed 
for this strain. If the theoretical maximum cell density of 220 g/l [124] could be achieved with 
ADP1 producing a WE content of DCW (8.6 ± 0.7 %), WE titers close to 20 g/l could be obtained. 
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However, high cell density cultivations would probably have to be carried out in fed-batch culti-
vations. Batch cultivations, such as the ones carried out in this thesis, do not provide the cells 
with enough nutrients to grow to high DCW or, if they do, the elevated nutrient concentrations 
start to inhibit growth. 
TABLE 6 WE titers obtained with different microorganisms. 
Strain WE titer (g/l) Reference 
A. baylyi ADP1 0.16 [162]  
A. baylyi ADP1_pykF 0.15 Publication III 
A. baylyi ADP1ΔrmlA_pykF 0.19 Publication III 
A. baylyi ADP1ΔrmlA_pykF 0.31 Publication IV 
A. baylyi ADP1ΔrmlAΔpoxB_pykF 0.45 Publication IV 
E. coli engineered for MBE production 0.79 [118] 
E. gracilis 2.1 [71] 
5.2.3 Wax ester content of the biomass 
The wax ester content of ADP1 was increased in the experiments of this thesis to 8.6 % (Table 
7). The highest yield of de novo-produced WEs obtained with bacteria (14 %) was obtained by 
cultivating A. calcoaceticus NCIB 10487 on succinate [56]. This value is ~1.6 times higher than 
the value obtained here with ADP1ΔrmlAΔpoxB_pykF (Publication IV). It might be worthwhile to 
better characterize the strain NCIB 10487 to find out if it is suitable for bioprocesses and meta-
bolic engineering. R. jostii RHA1 has also been shown to accumulate large amounts (13 %) of 
WEs, but this strain had to be grown for 72 hours to achieve that value [156]. Kalscheuer and 
Steinbüchel have reported a WE yield of 6.9 % w/v when cultivating APD1 for 24 hours on Na-
gluconate in a medium containing 0.1 g/l NH4Cl [87]. In Publications III and IV, where similar WE 
contents of biomass were obtained in cultivations of a similar length, the growth media contained 
1.0 g/l NH4Cl and 2.0 g/l CAA. Thus, ADP1ΔrmlAΔpoxB_pykF might be able to produce higher 
WE content in either longer cultivations (where the carbon to nitrogen ratio increases due to 
depletion of NH4Cl) or in cultivations in poorer media. Even though significant improvements in 
the WE content of ADP1 were achieved, the highest value obtained is still ~17 % of that of the 
Jojoba plant seeds, and the metabolism of ADP1ΔrmlAΔpoxB_pykF would have to be further 
engineered to improve this value. 
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TABLE 7 The highest WE contents of biomass obtained with different organisms. 
Organism Carbon source(s) WEs (% of DCW) Reference 
Escherichia coli BL21(DE3)a Na-oleate (in LB medium) ~1 [89] 
A. calcoaceticus NCIB 8250 Succinate 2.5 – 3.0 [54] 
A. baylyi ADP1 Glucose, CAA 1.8 [162] 
A. baylyi ADP1 Na-gluconate 6.9 [87] 
A. baylyi ADP1ΔrmlA_pykFa Glucose, EtOH, CAA 7.2 Publication III 
A. baylyi ADP1ΔrmlAΔpoxB_pykFa Glucose, acetate, CAA 8.6 Publication IV 
R. jostii RHA1a Glucose 13 [156] 
A. calcoaceticus ATCC 17976 Acetate 13 [56] 
A. calcoaceticus NCIB 10487 Succinate 14 [56] 
Acinetobacter sp. M-1 N-Hexadecane 17 [72] 
E. gracilis SM-ZK EtOH 57 [71] 
S. chinensis (seeds) n.a. ~50 [158] 
aMetabolically engineered strain. 
5.2.4 Metabolism of the lignocellulosic carbon sources 
5.2.5 Overflow metabolism 
The formation of acetate or any other overflow metabolite could not be detected with ADP1_ctrl 
or ADP1_pykF cultivated on glucose (Publication I). However, when gluconate was used as a 
carbon source and ADP1_pykF had a similar growth rate, acetate and ethanol could be detected 
in the HPLC samples of ADP1_pykF. Thus it seems that the overflow metabolism of ADP1 can 
be triggered by expression of pykF but this occurs only when gluconate is used as a carbon 
source, but not on glucose. Gluconate has lower energy content than glucose and can be directly 
taken up and catabolized by the cells, while glucose needs to be oxidized into gluconate prior to 
being taken up. Thus, although the cells grew at similar rates on both carbon sources, the carbon 
flux towards metabolites that can be converted to acetate, pyruvate and acetyl-CoA, could have 
been larger when cultivated on gluconate. However, since bioprocesses using ADP1 most likely 
use glucose instead of gluconate as a carbon source, the overflow metabolism leading to acetate 
and ethanol production is not likely to be a problem. 
In Publication III it was shown that in the cultivations of ADP1ΔrmlA_pykF in a glucose medium, 
CAA, EtOH (from the Cm stock solution), acetate and low pH can be observed at the end of the 
cultivation at 26 h (Publication III). In publication IV it was shown that the acetate was formed in 
the medium by EtOH catabolism. In Publication III it was shown that ADP1ΔrmlA grows slower 
on acetate (and thus also consumed acetate slower) than ADP1. Thus the accumulation of ace-
tate to the growth medium by ADP1ΔrmlA_pykF could be explained simply by the fact that, if 
both strains produced acetate from EtOH, the consumption of acetate by ADP1ΔrmlA_pykF was 
merely slower than with ADP1_pykF. 
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The acetate production from EtOH and subsequent accumulation to the growth medium by 
ADP1ΔrmlA_pykF could be alleviated by poxB KO (Publication IV). The strain 
ADP1ΔrmlAΔpoxB_pykF also produced acetate, but consumed it much more rapidly in the pres-
ence of glucose than ADP1ΔrmlA_pykF, which prevented the pH from decreasing to the level 
that no longer supports growth. ADP1ΔrmlAΔpoxB_pykF consumed EtOH more rapidly than 
ADP1ΔrmlA_pykF when cultivated on EtOH as a sole carbon source, but unexpectedly, it also 
produced more acetate than ADP1ΔrmlA_pykF. Since the only difference between the strains 
was the poxB KO in ADP1ΔrmlAΔpoxB_pykF, it is unclear why this happened. Intuitively, one 
might assume that more acetate would accumulate if the cells had pyruvate oxidase activity, 
which produces acetate from pyruvate. On the other hand, since acetate is also produced as an 
intermediate of EtOH catabolism, the lack of pyruvate oxidase activity might allow more rapid 
growth as the cell can funnel more carbon into gluconeogenesis. This could thus allow a faster 
growth rate, leading to more acetate production due to the increased amount of enzymes for 
conversion of EtOH to acetate at elevated cell densities. 
5.2.6 Biodetoxification 
The oxidation of the main lignocellulosic sugars, glucose, xylose and arabinose, could be com-
pletely prevented by producing a gcd KO in ADP1. This strain, ADP1Δgcd, could rapidly con-
sume acetate and formate in a medium containing the aforementioned sugars. The presence of 
4-HB in the growth medium allowed ADP1Δgcd to consume formate more efficiently. Formate, 
unlike acetate, did not repress 4-HB catabolism. This allows the smallest organic acid to be con-
sumed faster, if acetate is depleted from the medium. Thus, although acetate represses con-
sumption of 4-HB, it might be expected that the lignocellulosic hydrolysate still contains other 
compounds in addition to 4-HB, once the acetate had been consumed. Because of this, there 
might not be sequential use of inhibitors, if they are treated as inhibitor groups (aromatic inhibitors, 
aliphatic inhibitors, etc.). However, the fact that 2.7 g/l of acetate seems to inhibit glucose con-
sumption is more troubling (Publication IV), as this would delay consumption of the most abun-
dant component of lignocellulosic hydrolysates, glucose. While this is not a problem in the de-
toxification of lignocellulosic hydrolysates, it might reduce the efficiency of gcd-containing strains. 
ADP1Δgcd tolerated glucose well up to 100 g/l, and also grew also at 150 g/l and was able to 
grow on an elevated concentration (10 g/l) of acetate. ADP1Δgcd did not start to consume sugars 
even in a seven-day cultivation where an OD600 value of ~5 was reached. With E. coli engineered 
not to consume lignocellulosic sugars, it has proven to be difficult to completely eliminate sugar 
consumption [100]. Thus, it seems that ADP1Δgcd might be more suitable for selective removal 
of acetate from sugar-containing solutions than the E. coli strain engineered for the same pur-
pose. However, a major limitation of using ADP1Δgcd as a detoxification strain is that it cannot 
grow on all growth inhibitors found in lignocellulosic hydrolysates, such as furfural, 5-hy-
droxymethylfurfural (5-HMF) and levulinate. Furfural and 5-HMF are often present in smaller 
quantities in lignocellulosic hydrolysates than acetate [179], but they have been shown to inhibit 
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growth and ethanol production by an ethanologenic E. coli at these concentrations [205]. Engi-
neering furfural degradation in ADP1 should be feasible, since this has already been achieved 
in P. putida S12 [96]. This should improve the performance of ADP1 as a biodetoxification strain 
and also as a host organism in other lignocellulose-utilizing bioprocesses, because this com-
pound could serve as an additional carbon source. 
ADP1Δgcd was used in the elimination of oxygen from closed cultivation tubes, which allowed 
H2 production by the obligatory anaerobe C. butyricum. Similar experiments have been carried 
out previously by Tran et al. who eliminated the need for O2 removal by N2 flushing by cultivating 
Bacillus subtilis, which also simultaneously saccharificated the starch, allowing acetone-butanol-
EtOH production by C. butyricum [184]. In addition to removing O2 from the lignocellulosic hy-
drolysates to allow cultivation of anaerobic microorganisms, ADP1Δgcd could also be engi-
neered to produce cellulases, to achieve further hydrolysis of cellulose, or other compounds that 
are beneficial to the organism fermenting the biodetoxified lignocellulosic hydrolysate. 
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ADP1 naturally accumulates WEs but the titers are not sufficiently high for the WE-producing bio-
processes to be economically feasible. ADP1 also grows slowly on glucose, the most common car-
bon source in bioprocesses, commits a large fraction of the carbon to EPS synthesis, and does not 
catabolize glucose in the presence of acetate. By engineering the metabolism of ADP1, it was pos-
sible to double the growth rate on glucose, improve the WE yield and purity by eliminating EPS 
capsule synthesis, and improve growth and WE production in the presence of acetate. 
The growth rate of ADP1 on glucose was increased to 0.42 h-1 by expressing pykF from E. coli K-12 
MG1655 (Publication I). This growth rate is still far from the values obtained, for example, with E. 
coli W3110 (~ 1.0 h-1) [3] but this improvement nevertheless halves the time needed to run the bio-
processes where WEs are produced with ADP1 from glucose. On the other hand, when compared 
to other WE-producing microorganisms like R. jostii (0.19 h-1 (when carrying an empty plasmid 
pNV18)) [202], the growth rate of ADP1_pykF obtained here is relatively high. The growth rate and 
biomass yield from glucose might be further improved by integrating pykF into the genome of ADP1, 
since maintenance of a plasmid is known to reduce growth rate and biomass yield [170]. This would 
also eliminate the need of supplementing the growth medium with antibiotics. The mass of the NMR 
sample in the experiment yielding the highest WE titer (0.45 ± 0.05 g/l) was relatively low (5.2 ± 0.1 
g/l) and WE production by ADP1 would benefit tremendously from the development of high cell-
density cultivations for this strain. 
By knocking out rmlA, the gene for the first step in the synthesis of the main component of EPS, it 
was possible to improve the WE yield of ADP1_pykF on glucose. This KO mutation also reduced the 
biomass yield from glucose and made it easier to collect the cells by centrifugation, thus improving 
the WE purity and reducing the cost of downstream processing. The effects of the rmlA KO mutation 
could not be extended to cultivations on acetate and 4-HB, which are also components of lignocel-
lulosic hydrolysates. While having a doubled WE yield from glucose, ADP1ΔrmlA_pykF had a de-
creased tolerance towards acetate produced from EtOH in the growth medium. This drawback could 
6 Conclusions 
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be eliminated by knocking out the gene for pyruvate oxidase, poxB, from the genome of 
ADP1ΔrmlA_pykF (Publication IV). Furthermore, the poxB KO improved the WE yield in a medium 
containing glucose and acetate as carbon sources. Since glucose and acetate are both among the 
most abundant carbon sources found in lignocellulosic hydrolysates, this modification should im-
prove the properties of ADP1 as a host organism in bioprocesses using this raw material. In the 
presence of glucose as a sole carbon source, the growth rate of ADP1ΔrmlAΔpoxB_pykF was lower 
than that of ADP1ΔrmlA_pykF, indicating that, as with E. coli W3110 [3], pyruvate oxidase is bene-
ficial when cultivated on this carbon source. Because of this, it might be beneficial to control expres-
sion of poxB in ADP1ΔrmlA_pykF so that the gene is expressed when only glucose is present, but 
not in the presence of both glucose and acetate. 
When the gene for GDH, gcd, was knocked out from the genome of ADP1, the strain was rendered 
completely unable to catabolize lignocellulosic sugars (Publication II). These kinds of strains are 
suitable for the selective removal of growth inhibitors from lignocellulosic hydrolysates. The initial 
characterization of ADP1Δgcd indicated that it could perform efficiently as a biodetoxification strain, 
although the robustness of the strain should be tested with different kinds of lignocellulosic hydroly-
sates. Also, since the strain is unable to consume, for example, furfural and 5-HMF, the growth 
substrate range of this organism should be broadened to include these inhibitors. 
In this Doctor of Science thesis it was shown that the properties of ADP1 as a host organism in WE-
producing bioprocesses can be readily improved with metabolic engineering, and that this organism 
has the potential to become an efficient host organism in the biodetoxification of lignocellulosic hy-
drolysates. While the modifications made here improved both growth characteristics and WE-
production, the catabolic capabilities of this organism should be broadened to allow consumption of 
other lignocellulosic sugars in addition to glucose. The robustness of ADP1 also needs to be eluci-
dated by characterizing its growth in actual lignocellulosic hydrolysates. As biodetoxification using 
ADP1Δgcd is time-consuming, it might be necessary to engineer other functions like cellulase pro-
duction to ADP1Δgcd to make biodetoxification using this strain more attractive. The WE structure 
could be tailored for specific applications, which would increase the value of this product. The devel-
opment of a strain for the production of tailored WEs with better properties than those of the Jojoba 
plant would make it much more likely that ADP1 could be used in industrial WE production. The rapid 
development of the field of synthetic biology should make it increasingly easy to achieve these goals. 
In addition to engineering the metabolism of ADP1, cultivation techniques should be developed 
which allow the generation of high cell-density, since only that could allow a high titer of intracellularly 
accumulating WEs to be produced. The WE titers obtained in this thesis are still far from being high 
enough for industrial production for applications such as biofuels. Nevertheless, hopefully the pro-
gress presented in this thesis will encourage other researchers to pursue the goal of engineering 
ADP1 into an efficient WE producer. 
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